MeilensteinMeldung bei spekulativer ChinaAktie - 500 Beiträge pro Seite (Seite 2)
eröffnet am 02.05.06 03:18:38 von
neuester Beitrag 21.11.07 14:39:43 von
neuester Beitrag 21.11.07 14:39:43 von
Beiträge: 608
ID: 1.057.135
ID: 1.057.135
Aufrufe heute: 0
Gesamt: 53.822
Gesamt: 53.822
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| heute 01:06 | 582 | |
| heute 01:38 | 293 | |
| vor 1 Stunde | 274 | |
| gestern 22:44 | 247 | |
| 08.05.24, 11:56 | 219 | |
| gestern 22:52 | 210 | |
| vor 1 Stunde | 160 | |
| gestern 23:15 | 141 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.772,85 | +0,46 | 131 | |||
| 2. | 3. | 0,2170 | +3,33 | 125 | |||
| 3. | Neu! | 8,8800 | +57,45 | 108 | |||
| 4. | 4. | 168,47 | -2,04 | 103 | |||
| 5. | 14. | 5,7540 | -2,18 | 56 | |||
| 6. | 2. | 0,2980 | -3,87 | 50 | |||
| 7. | 5. | 2,5600 | -6,91 | 49 | |||
| 8. | 7. | 6,8000 | +2,38 | 38 |
Feedback
Antwort auf Beitrag Nr.: 27.659.156 von MKostolany am 12.02.07 13:53:49
ich glaúb nach diesen guten news können wer wieder etwas gelassnener in die zukunft schauen.
jetzt noch die zahlen für das erste quartal, bestätigen oder verbessern, noch ein zwei gute beteiligungen und wir sind wieder über den 0,20 € undd ann weiter ganz sicher.
da kann mann den text auch gern mal in einer schlechten übersetzung und gekürzt ertragen oder
Genesis Technology Group, Inc. Vermelden einen reviedierten jährlichen Bericht 2006 mit einem Gesamtertrag von $7.2 Million und einem Reineinkommen von $2.9 Millionen.
Genesis Technology Group, Inc. (OTCBB:GTEC) gab seinen jährlichen Bericht für steuerliches Jahr 2006, die Archivierung 10-KSB frei, wie durch Sherb & Company von New York revidiert. Die Firma erwirtschaftete ein Reineinkommen von $2.9 Million und einen Gesamtertrag von $7.2 Millionen und schloss das Jahr als erfolgreichstes in der Geschichte ab.
Dieses stellt zum Reineinkommen von $0.03 pro allgemeinen Anteil gleich. Herr Adam Wasserman, der als der Genese-Finanzleiter seit Oktober 2001 gedient hat, berichtet: "der finanzielle Zustand der Firma fährt fort, Fortschritte zu zeigen. Für das Jahr 2006, beendet September 30, 2006, berichteten wir über Reineinkommen von $2.909.606 oder von $0.03 pro allgemeinen Anteil, verglichen mit einem Reinverlust von $(3,726,929) oder von $(0.06) pro allgemeinen Anteil für das Jahr beendete September 30, 2005, eine positive Zunahme von $6.636.535. "ab September 30, 2006, betrugen die des Company\s Gesamtwerte bis $7.231.773, verglichen bis $1.719.042 an September 30, 2005.
Unsere Gesamtbetriebskosten verringerten sich um $1.066.815 verglichen mit den vorhergehenden 12 Monaten des Betriebes. Herr Gary L. Wolfson, Hauptgeschäftsführer-Büro, "unser Management hatte zwei jahre zuvor die schwierige aufgabe die fa. wieder auf vordermann zu bringen.
Sie erforderte harte Entscheidungen und entscheidende Tätigkeiten, und wir glauben, daß unsere Resultate beginnen verwirklicht zu werden.
Wir haben Mannschaften in den VEREINIGTEN STAATEN zusammengebaut, die auf höchstem Niveau Professionalismus beibehalten und die Fähigkeiten besitzen, um die Herausforderungen, die uns von der chinesischen wirtschaft bereitgestellt werden, zu bewältigen.
ich glaube alles andere ist nicht so wichtig oder.
also freuen wir uns auf hoffentlich bessere kurse.
ich glaúb nach diesen guten news können wer wieder etwas gelassnener in die zukunft schauen.
jetzt noch die zahlen für das erste quartal, bestätigen oder verbessern, noch ein zwei gute beteiligungen und wir sind wieder über den 0,20 € undd ann weiter ganz sicher.
da kann mann den text auch gern mal in einer schlechten übersetzung und gekürzt ertragen oder
Genesis Technology Group, Inc. Vermelden einen reviedierten jährlichen Bericht 2006 mit einem Gesamtertrag von $7.2 Million und einem Reineinkommen von $2.9 Millionen.
Genesis Technology Group, Inc. (OTCBB:GTEC) gab seinen jährlichen Bericht für steuerliches Jahr 2006, die Archivierung 10-KSB frei, wie durch Sherb & Company von New York revidiert. Die Firma erwirtschaftete ein Reineinkommen von $2.9 Million und einen Gesamtertrag von $7.2 Millionen und schloss das Jahr als erfolgreichstes in der Geschichte ab.
Dieses stellt zum Reineinkommen von $0.03 pro allgemeinen Anteil gleich. Herr Adam Wasserman, der als der Genese-Finanzleiter seit Oktober 2001 gedient hat, berichtet: "der finanzielle Zustand der Firma fährt fort, Fortschritte zu zeigen. Für das Jahr 2006, beendet September 30, 2006, berichteten wir über Reineinkommen von $2.909.606 oder von $0.03 pro allgemeinen Anteil, verglichen mit einem Reinverlust von $(3,726,929) oder von $(0.06) pro allgemeinen Anteil für das Jahr beendete September 30, 2005, eine positive Zunahme von $6.636.535. "ab September 30, 2006, betrugen die des Company\s Gesamtwerte bis $7.231.773, verglichen bis $1.719.042 an September 30, 2005.
Unsere Gesamtbetriebskosten verringerten sich um $1.066.815 verglichen mit den vorhergehenden 12 Monaten des Betriebes. Herr Gary L. Wolfson, Hauptgeschäftsführer-Büro, "unser Management hatte zwei jahre zuvor die schwierige aufgabe die fa. wieder auf vordermann zu bringen.
Sie erforderte harte Entscheidungen und entscheidende Tätigkeiten, und wir glauben, daß unsere Resultate beginnen verwirklicht zu werden.
Wir haben Mannschaften in den VEREINIGTEN STAATEN zusammengebaut, die auf höchstem Niveau Professionalismus beibehalten und die Fähigkeiten besitzen, um die Herausforderungen, die uns von der chinesischen wirtschaft bereitgestellt werden, zu bewältigen.
ich glaube alles andere ist nicht so wichtig oder.
also freuen wir uns auf hoffentlich bessere kurse.
Antwort auf Beitrag Nr.: 27.659.156 von MKostolany am 12.02.07 13:53:49
un dwohin das damals ging wissen wer ja noch.
auf über 0,40 cent
un dwohin das damals ging wissen wer ja noch.auf über 0,40 cent
Antwort auf Beitrag Nr.: 27.660.246 von Petrohunter am 12.02.07 14:55:01Ich kenn die Zeit, habe damals gute Gewinne mitgenommen. Leider habe ich aber auch aus dieser Zeit noch einen Restbestand... Werde dann wohl nochmals nachkaufen. Jetzt gehts UP
Antwort auf Beitrag Nr.: 27.660.297 von MKostolany am 12.02.07 14:57:58
hab mit genesis auch gute gewinne erzielt, hab aber leider auch noch en grösseren restbestand von 0,25 ich hoffe ich kannn den jetzt bald ausgleichen gg
hab mit genesis auch gute gewinne erzielt, hab aber leider auch noch en grösseren restbestand von 0,25 ich hoffe ich kannn den jetzt bald ausgleichen gg
Antwort auf Beitrag Nr.: 27.660.593 von Petrohunter am 12.02.07 15:11:56 wär ja bis ende des jahres mit 0,30 schon zufrieden, aber das wird schwer genug.
ich denke jetzt gehts hin und her, hoffentlich kann sie sich in den nächsten wochen oder monaten wenigstens mal an die 0,20 ranpirschen.
und leute wir haben die zahlen jetzt auf englisch in deutsch.
es reicht jetzt
wär ja bis ende des jahres mit 0,30 schon zufrieden, aber das wird schwer genug.ich denke jetzt gehts hin und her, hoffentlich kann sie sich in den nächsten wochen oder monaten wenigstens mal an die 0,20 ranpirschen.
und leute wir haben die zahlen jetzt auf englisch in deutsch.
es reicht jetzt
Trading Spotlight
Schläft der Umsatz in Deutschland ein ?
Sehr schlechte BID/ASK taxe !!!!
Interessiert die Zahlen keiner ?
Sehr schlechte BID/ASK taxe !!!!
Interessiert die Zahlen keiner ?
Antwort auf Beitrag Nr.: 27.685.812 von chocobr am 13.02.07 17:31:12 die warten schon wieder auf die nächsten zaheln ob gen die bestätigt. 
.
was meint ihr werden wer die 0,40 dieses jahr noch schaffen
die warten schon wieder auf die nächsten zaheln ob gen die bestätigt. 
.was meint ihr werden wer die 0,40 dieses jahr noch schaffen
Glaub schon, das die 0,40 im Laufe des Jahres ein Thema sein wird.
Der Gewinn v. Lotus wurde doch im Dezember ausgewiesen und müsste
sich auf die Zahlen per 30.12.06 auswirken.
Weiss jemand wann diese Zahlen kommen ??
Der Gewinn v. Lotus wurde doch im Dezember ausgewiesen und müsste
sich auf die Zahlen per 30.12.06 auswirken.
Weiss jemand wann diese Zahlen kommen ??
"grösseren restbestand"
also das Hauptpaket ist dick im Minus...^^
also das Hauptpaket ist dick im Minus...^^
Q-Zahlen sind da - aber eher entäuschend - 0 Einnahmen, 685k Verlust
http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx…
Ein Auszug:
RESULTS OF OPERATIONS
THREE MONTHS ENDED DECEMBER 31, 2006 COMPARED THE THREE MONTHS ENDED DECEMBER
31, 2005
REVENUES
For the three months ended December 31, 2006, we had consolidated revenues of $0 as compared to $5,000 for the three months ended December 31, 2005, a decrease of $5,000 or 100%. During the three months ended December 31, 2006, we spent a substantial amount of time coordinating and facilitating the completion of services in connection with the agreement entered between GEP and Jin Ma Group Company, Ltd. ("Jin Ma"), a real estate development company in Western China. We anticipate that this transaction will be completed in the near future at such time GEP will receive a significant equity position in Gold Horse and ongoing consulting fees for coordination and oversight of its U.S. business activities. We currently have a limited number of client companies, and for the year ended September 30, 2006, one of our clients represented approximately 99.9% of our total revenues. While we continue to market our consulting services, we may need to raise additional working capital to fund our daily operations and the commitments to our client contracts. Accordingly, we may be limited in the amount of engagements we accept from additional consulting clients, thereby limiting our ability to generate revenues in future periods. We cannot assure you that we will ever be able to successfully implement our expanded business model or increase our revenues in future periods.
OPERATING EXPENSES
For the three months ended December 31, 2006, operating expenses which include consulting fees, salaries and non-cash compensation, and other selling, general and administrative, were $848,224 compared to $271,242 for the three months ended December 31, 2005,an increase of $576,982 or 213%.
OVERALL
We reported net loss for the three months ended December 31, 2006 of $675,282 compared to a net loss for the three months ended December 31, 2005 of $223,123. This translates to an overall per-share loss available to shareholders of $.01 for the three months ended December 31, 2006 compared to per-share loss of $0 for three months ended December 31, 2005.
http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx…
Ein Auszug:
RESULTS OF OPERATIONS
THREE MONTHS ENDED DECEMBER 31, 2006 COMPARED THE THREE MONTHS ENDED DECEMBER
31, 2005
REVENUES
For the three months ended December 31, 2006, we had consolidated revenues of $0 as compared to $5,000 for the three months ended December 31, 2005, a decrease of $5,000 or 100%. During the three months ended December 31, 2006, we spent a substantial amount of time coordinating and facilitating the completion of services in connection with the agreement entered between GEP and Jin Ma Group Company, Ltd. ("Jin Ma"), a real estate development company in Western China. We anticipate that this transaction will be completed in the near future at such time GEP will receive a significant equity position in Gold Horse and ongoing consulting fees for coordination and oversight of its U.S. business activities. We currently have a limited number of client companies, and for the year ended September 30, 2006, one of our clients represented approximately 99.9% of our total revenues. While we continue to market our consulting services, we may need to raise additional working capital to fund our daily operations and the commitments to our client contracts. Accordingly, we may be limited in the amount of engagements we accept from additional consulting clients, thereby limiting our ability to generate revenues in future periods. We cannot assure you that we will ever be able to successfully implement our expanded business model or increase our revenues in future periods.
OPERATING EXPENSES
For the three months ended December 31, 2006, operating expenses which include consulting fees, salaries and non-cash compensation, and other selling, general and administrative, were $848,224 compared to $271,242 for the three months ended December 31, 2005,an increase of $576,982 or 213%.
OVERALL
We reported net loss for the three months ended December 31, 2006 of $675,282 compared to a net loss for the three months ended December 31, 2005 of $223,123. This translates to an overall per-share loss available to shareholders of $.01 for the three months ended December 31, 2006 compared to per-share loss of $0 for three months ended December 31, 2005.
jetzt schmeissen die schon wieder wegen der paar lumpigen gewinne.man man
glaub nicht das wir noch dieses jahr an die 0,40 rankommen, dann müssten die zahlen schon super ausfallen.
o,27 wäre auch ok
Antwort auf Beitrag Nr.: 27.715.178 von wayne99 am 15.02.07 08:07:18Der Ausblick für 2007 ist auch da. Naja, eher nichts neues. Ich hoffe, das Geld reicht noch um dieses Jahr ohne Kapitalerhöhung beenden zu können.
Berlin-Bremen 20.02./09:10 0,086 -13,13%
Was der Makler in Berlin wieder taxt... *ohne Worte*
Was der Makler in Berlin wieder taxt... *ohne Worte*
Antwort auf Beitrag Nr.: 27.708.115 von mindgames1001 am 14.02.07 17:42:26
woher willst das wissen, kennst du meine verkäufe?
ansonsten solltest ruhe bwahren und posten wenn was vernünftiges ansteht ok
woher willst das wissen, kennst du meine verkäufe?ansonsten solltest ruhe bwahren und posten wenn was vernünftiges ansteht ok
Antwort auf Beitrag Nr.: 21.397.329 von mindgames1001 am 02.05.06 03:18:38Genesis Chinese Partner Companies Complete Pre-Audit Process to Advance Toward Public Company Status
PrintE-mailDisable live quotesRSSDigg itDel.icio.us
Last Update: 6:31 AM ET Feb 21, 2007
BEIJING, Feb 21, 2007 (PrimeNewswire via COMTEX) -- Genesis Technology Group, Inc. (GTEC : genesis technology group inc com
News , chart, profile, more
Last: 0.140.000.00%
12:24am 02/23/2007
Delayed quote dataAdd to portfolio
Analyst
Create alertInsider
Discuss
Financials
Sponsored by:
GTEC0.14, 0.00, 0.0%) announced that its Chinese partners, the third and fourth members of its capital and growth expansion program, have completed the pre-audit process conducted by a certified public accounting firm in Beijing. The reports have been conveyed to U.S. auditing firms to commence the next phase, which is intended to result in U.S. public company status, perhaps during calendar year 2007. If completed, Genesis should receive a significant equity position in each new public entity.
The Chinese environmental technologies company, which provides power generation and industrial dyeing enterprises with proprietary cleanup equipment, has formally engaged an auditing firm in New York and a Shanghai-based law firm to handle its in-China legal matters.
Through November 2006, this "green power" company reported unaudited, net profits of about $4 million after taxes, an increase of nearly 100% from fiscal year 2005. Its total assets exceeded $15.5 million, based on information provided by the accounting firm.
The Chinese health foods beverage company completed the pre-audit procedure in February 2007. Now, it is in the process of formally engaging a qualified U.S. auditor. This Chinese company produces a wide array of beverages, including yogurt drinks that presently sell in California, in addition to its 15-province market coverage in China.
Through December 2006, this health foods beverage company reported unaudited, net profits of about $1.4 million. Its total assets exceeded $15 million, based on information provided by the accounting firm.
From his Beijing office, Genesis Director Dr. Shaohua Tan stated: "Additional candidate partner companies are being screened in China by the Genesis team. Our goal is to sign up 4-6 new partners in the next 12-18 months. Each could provide Genesis with substantial profits and assets enhancement.
"However, this is a challenging and risk-laden process. Followers of the Genesis business model must understand that, until the Chinese partner company officially reaches public company status and files its initial Form 8-K, a high degree of risk exists that the partner may not ever attain that status. While the receipt of such stock is contractual, Genesis still recognizes that such compensation is conditional on performance and specific deliverables," reminded Dr. Tan.
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that earns, enhances and markets equity positions in small to mid-sized Chinese enterprises. Commitment, dedication, and expertise are the key components to the Genesis "Mission Statement." It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined "partner companies." Genesis makes a long-term commitment with management consultation, board of directors' composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.net.
Safe Harbor Statement
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
This news release was distributed by PrimeNewswire, www.primenewswire.com
SOURCE: Genesis Technology Group, Inc.
Genesis Technology Group, Inc.
Kenneth Clinton, President
(561) 988.9880
Fax: (561) 988-9890
info@Genesis-China.net
PrintE-mailDisable live quotesRSSDigg itDel.icio.us
Last Update: 6:31 AM ET Feb 21, 2007
BEIJING, Feb 21, 2007 (PrimeNewswire via COMTEX) -- Genesis Technology Group, Inc. (GTEC : genesis technology group inc com
News , chart, profile, more
Last: 0.140.000.00%
12:24am 02/23/2007
Delayed quote dataAdd to portfolio
Analyst
Create alertInsider
Discuss
Financials
Sponsored by:
GTEC0.14, 0.00, 0.0%) announced that its Chinese partners, the third and fourth members of its capital and growth expansion program, have completed the pre-audit process conducted by a certified public accounting firm in Beijing. The reports have been conveyed to U.S. auditing firms to commence the next phase, which is intended to result in U.S. public company status, perhaps during calendar year 2007. If completed, Genesis should receive a significant equity position in each new public entity.
The Chinese environmental technologies company, which provides power generation and industrial dyeing enterprises with proprietary cleanup equipment, has formally engaged an auditing firm in New York and a Shanghai-based law firm to handle its in-China legal matters.
Through November 2006, this "green power" company reported unaudited, net profits of about $4 million after taxes, an increase of nearly 100% from fiscal year 2005. Its total assets exceeded $15.5 million, based on information provided by the accounting firm.
The Chinese health foods beverage company completed the pre-audit procedure in February 2007. Now, it is in the process of formally engaging a qualified U.S. auditor. This Chinese company produces a wide array of beverages, including yogurt drinks that presently sell in California, in addition to its 15-province market coverage in China.
Through December 2006, this health foods beverage company reported unaudited, net profits of about $1.4 million. Its total assets exceeded $15 million, based on information provided by the accounting firm.
From his Beijing office, Genesis Director Dr. Shaohua Tan stated: "Additional candidate partner companies are being screened in China by the Genesis team. Our goal is to sign up 4-6 new partners in the next 12-18 months. Each could provide Genesis with substantial profits and assets enhancement.
"However, this is a challenging and risk-laden process. Followers of the Genesis business model must understand that, until the Chinese partner company officially reaches public company status and files its initial Form 8-K, a high degree of risk exists that the partner may not ever attain that status. While the receipt of such stock is contractual, Genesis still recognizes that such compensation is conditional on performance and specific deliverables," reminded Dr. Tan.
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that earns, enhances and markets equity positions in small to mid-sized Chinese enterprises. Commitment, dedication, and expertise are the key components to the Genesis "Mission Statement." It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined "partner companies." Genesis makes a long-term commitment with management consultation, board of directors' composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.net.
Safe Harbor Statement
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
This news release was distributed by PrimeNewswire, www.primenewswire.com
SOURCE: Genesis Technology Group, Inc.
Genesis Technology Group, Inc.
Kenneth Clinton, President
(561) 988.9880
Fax: (561) 988-9890
info@Genesis-China.net
Maydorn hat Genesis Technol. auf seine Wachtliste genommen.
"Titel mit überdurchschnittlich viel Potienzial. Auf jeden Fall
behalten oder sogar kaufen"
Wird endlich mal Zeit, das Schwung in die Aktie kommt.
"Titel mit überdurchschnittlich viel Potienzial. Auf jeden Fall
behalten oder sogar kaufen"
Wird endlich mal Zeit, das Schwung in die Aktie kommt.
Volumen knapp ne halbe Mio. in der ersten Std. - nicht schlecht. Was ist denn hier passiert?!?!
Antwort auf Beitrag Nr.: 27.974.814 von MKostolany am 26.02.07 10:48:59 maydorn syndrom gg
hoffentlich gehts jetzt endlich mal aufwärts mensch
zahlen waren doch gut und werden sicher noch besser.
maydorn syndrom gghoffentlich gehts jetzt endlich mal aufwärts mensch
zahlen waren doch gut und werden sicher noch besser.
und wieder gehts abwärts...maydorn nützt da auch nichts vielleicht auch gut so
Warum gehts denn heute schon wieder Richung Süden?
Antwort auf Beitrag Nr.: 28.009.735 von Yarhoot am 27.02.07 18:41:51 nweil die paar dollar gewinn den markt nicht zum kauf animierebn
da muss nach dem riesencrash jetzt mal mehr kommen in nächster zeit, sonst sind wir bald wieder bei 0,05.
scheiss manchmal kapierst den markt echt nicht.
ermürbungstaktik, wer wirft zuerst..verliert zuerst die geduld, damit die andern wieder billig einkaufen können.
ich glaube hier wird erst mal ne weil,e gezockt bis es wieder richtig aifwärts geht.
geduld ist hier gefragt.
ich lass die aktie jetzt einfach mal links liegen.
nweil die paar dollar gewinn den markt nicht zum kauf animierebnda muss nach dem riesencrash jetzt mal mehr kommen in nächster zeit, sonst sind wir bald wieder bei 0,05.
scheiss manchmal kapierst den markt echt nicht.
ermürbungstaktik, wer wirft zuerst..verliert zuerst die geduld, damit die andern wieder billig einkaufen können.
ich glaube hier wird erst mal ne weil,e gezockt bis es wieder richtig aifwärts geht.
geduld ist hier gefragt.
ich lass die aktie jetzt einfach mal links liegen.
Jeder der den letzten Quartalsbericht gelesen (verstanden) hat, weiß, dass die Kohle bei Gtec noch für ca. ein halbes Jahr reicht (Die Beteiligungen, die Gtec besitzt sind bis auf weiteres nicht zu versilbern).
Es gibt mit Sicherheit schon Gesellschaften, die auf eine Kapitalerhöhung bei Gtec warten bzw. lauern. Und die haben ein großes Interesse daran, dass der Kurs bis dahin nicht große Sprünge nach oben macht. Die Leute, die ihre Aktien in den USA zum Teil in Mini-Paketen wegschmeissen, sind bestimmt keine enttäuschten Anleger, sondern Leute, die den Kurs niedrig halten wollen. Und wenn auf der anderen Seite kein Kaufinteresse besteht, haben die natürlich ein leichtes Spiel.
Es gibt mit Sicherheit schon Gesellschaften, die auf eine Kapitalerhöhung bei Gtec warten bzw. lauern. Und die haben ein großes Interesse daran, dass der Kurs bis dahin nicht große Sprünge nach oben macht. Die Leute, die ihre Aktien in den USA zum Teil in Mini-Paketen wegschmeissen, sind bestimmt keine enttäuschten Anleger, sondern Leute, die den Kurs niedrig halten wollen. Und wenn auf der anderen Seite kein Kaufinteresse besteht, haben die natürlich ein leichtes Spiel.
Antwort auf Beitrag Nr.: 28.011.949 von aktienmc am 27.02.07 20:23:43 wieso für ein halbes jahr...dass musst mir mal näher erklären.
wenn das so wäre könnten sie heute schon zumachen oder sofort eine kapitalerhöhung anstreben.
denn das wäre ja harakiri so lange zu warten.
aber sicher ist die brauchen beteilugungewn so schnell wie möglich, sonst ist hier bald fertig.
hab irgendwie kein gutes gefühl mehr bei der firma.
wieso für ein halbes jahr...dass musst mir mal näher erklären.wenn das so wäre könnten sie heute schon zumachen oder sofort eine kapitalerhöhung anstreben.
denn das wäre ja harakiri so lange zu warten.
aber sicher ist die brauchen beteilugungewn so schnell wie möglich, sonst ist hier bald fertig.
hab irgendwie kein gutes gefühl mehr bei der firma.
Nee ich auch nicht GTEC ist bei mir so was von im Keller!
Antwort auf Beitrag Nr.: 28.026.892 von Yarhoot am 28.02.07 15:21:00
nicht nur bei dir.
mein grösster fehler hier nicht früher ausgestiegen zu sein.
nicht nur bei dir.mein grösster fehler hier nicht früher ausgestiegen zu sein.
gibts was neues? in den ersten 15min super volumen und 7,5 % ++++
Das hier ist schon ein paar Tage alt.
Wurde aber wohl noch nicht gepostet...
Genesis Reports $3 Million Financing for Chinese Partner Company
BEIJING, March 1, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) announced that Lotus Pharmaceuticals, Inc. (OTC BB:LTUS.OB - News) has completed a $3 million financing with a U.S.-based investment fund. The Beijing-based pharmaceutical company is a graduate of the Genesis growth and capital program, which operates under the subsidiary name, Genesis Equity Partners, LLC ("GEP").
Dr. Liu Zhongyi, Lotus CEO, commented: "This $3 million investment provides Lotus with additional capital resources to better deploy and expand our product line, improve our balance sheet and execute our strategic business plan that is focused on marketing, acquisitions and corporate development. We are grateful for the guidance provided by our partner, GEP. Genesis's dedication and leadership assisted our transformation and impressively increased the value of Lotus. This initial funding is the beginning for Lotus, as Western capital will enable our Company to establish a presence first nationally, then internationally amongst China-based pharmaceuticals."
Dr. Shaohua Tan, Genesis Director in China, observed: "The GEP program should significantly strengthen Genesis' profit-earning capability over the long run. Indeed, the large majority of 2006 income of the Company came from only one partnering company, Lotus Pharmaceuticals. We have now signed up three additional companies, with expected project completion dates in the foreseeable future, possibly in this calendar year. What's more, Genesis believes that it could be able to qualify and sign up as many as six new partnering Chinese companies over the next 12-18 months, which could put Genesis on the fast-growth track for years to come."
Wurde aber wohl noch nicht gepostet...
Genesis Reports $3 Million Financing for Chinese Partner Company
BEIJING, March 1, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) announced that Lotus Pharmaceuticals, Inc. (OTC BB:LTUS.OB - News) has completed a $3 million financing with a U.S.-based investment fund. The Beijing-based pharmaceutical company is a graduate of the Genesis growth and capital program, which operates under the subsidiary name, Genesis Equity Partners, LLC ("GEP").
Dr. Liu Zhongyi, Lotus CEO, commented: "This $3 million investment provides Lotus with additional capital resources to better deploy and expand our product line, improve our balance sheet and execute our strategic business plan that is focused on marketing, acquisitions and corporate development. We are grateful for the guidance provided by our partner, GEP. Genesis's dedication and leadership assisted our transformation and impressively increased the value of Lotus. This initial funding is the beginning for Lotus, as Western capital will enable our Company to establish a presence first nationally, then internationally amongst China-based pharmaceuticals."
Dr. Shaohua Tan, Genesis Director in China, observed: "The GEP program should significantly strengthen Genesis' profit-earning capability over the long run. Indeed, the large majority of 2006 income of the Company came from only one partnering company, Lotus Pharmaceuticals. We have now signed up three additional companies, with expected project completion dates in the foreseeable future, possibly in this calendar year. What's more, Genesis believes that it could be able to qualify and sign up as many as six new partnering Chinese companies over the next 12-18 months, which could put Genesis on the fast-growth track for years to come."
Hab denen heute mal ne E-Mail geschrieben, dass ich besorgt über den Aktienkurs wäre und ob Sie sich das erklären könnten. Weiterhin würd ich gern wissen, ob in nächster Zeit Nachrichten oder Aktivitäten anstünden, die den Kurs nachhaltig stützen würden.....
Antwort:
"Sir,
I have really no reason or answer for you. We are trying to execute our business plan and hope that the results will increase our evaluation long term.
Genesis China"
Antwort:
"Sir,
I have really no reason or answer for you. We are trying to execute our business plan and hope that the results will increase our evaluation long term.
Genesis China"
Antwort auf Beitrag Nr.: 28.170.807 von Wiss911 am 07.03.07 18:39:47
hab ich auch schon, da kommt keine reaktion.
oder mein englisch ist zu schlecht
ich hoffe immer noch auf die olympiade in china vielleicht hilfts bis dahin sehe ich keine grossen kurssteigerungen, leider
hab ich auch schon, da kommt keine reaktion.oder mein englisch ist zu schlecht
ich hoffe immer noch auf die olympiade in china vielleicht hilfts bis dahin sehe ich keine grossen kurssteigerungen, leider
Ja das is so ein Invest..... ich denke hier ist ganz langfristig bestimmt was drin, aber so schnell wird sich da nix tun! Ich versuch erstmal zu meinem EK rauszukommen.... sieht nur leider schlecht aus im Moment
aber auf der Watchlist bleibt Gtech auf jeden Fall
aber auf der Watchlist bleibt Gtech auf jeden Fall
Antwort auf Beitrag Nr.: 28.178.420 von Wiss911 am 08.03.07 09:53:34 seh ich auch so mach ich auch so, aber bis dahin ist für mich noch ein langer weg
seh ich auch so mach ich auch so, aber bis dahin ist für mich noch ein langer weg ich denk zumindest das bei 0,90-1.-€ erst mal en boden gefunden ist.bei guten news sind wir dann schnell auf 0,20 und weiter
Genesis Releases CEO Letter Forecasting Strong Performance
3/7/2007
BOCA RATON, Fla., Mar 7, 2007 (PrimeNewswire via COMTEX News Network) --
Genesis Technology Group, Inc. (OTCBB:GTEC) released a letter from its Chief Executive Officer and Board of Directors that summarizes the Company's historic success recorded in fiscal year 2006 and forecasts even stronger performance in the future. The communication states that profits reaching $20 million and assets of $30 million are considered possible, based on current performance and trends.
The complete letter is accessible at http://www.genesis-china.net/letters.html, on the Genesis website, or by email and regular mail upon requests made to the Corporate Headquarters in Boca Raton, Florida.
Among the key points of the letter are:
-- For fiscal year 2006, the Company reported net income of $2.9
million and assets of $7.2 million, making the year its most
successful in its history. This equated to net income of $0.03
per common share, fully diluted, and a positive increase,
year-to-year, of $6.6 million. Its revenues reached $6,750,229 as
compared to $154,580 for the year ended September 30, 2005, an
increase of $6,595,649 or 4267%.
-- From its evolving Genesis Equity Partners program, an umbrella of
limited liability subsidiaries, the Company believes that it
could generate at least $2 million in profits from each Chinese
partner company. Such projected profits are based on the first
graduate of the revitalized program, Lotus Pharmaceuticals, Inc.
(OTCBB:LTUS) that actually produced profits far exceeding these
levels. Genesis projects it could add as many as six new partners
to its existing four contracts, and envisions profits possibly
reaching $20 million and assets of $30 million or more.
-- Management holds that forming a turnkey operation coupled with
sustainability and repeated success should convince the U.S.
investment community that Genesis is for real and deserves the
consistent support that would limit the current vagaries and
uncertainties of the Bulletin Board market place. The letter
concludes by stating that "management has reached the point that
it welcomes being judged by results and not promises."
3/7/2007
BOCA RATON, Fla., Mar 7, 2007 (PrimeNewswire via COMTEX News Network) --
Genesis Technology Group, Inc. (OTCBB:GTEC) released a letter from its Chief Executive Officer and Board of Directors that summarizes the Company's historic success recorded in fiscal year 2006 and forecasts even stronger performance in the future. The communication states that profits reaching $20 million and assets of $30 million are considered possible, based on current performance and trends.
The complete letter is accessible at http://www.genesis-china.net/letters.html, on the Genesis website, or by email and regular mail upon requests made to the Corporate Headquarters in Boca Raton, Florida.
Among the key points of the letter are:
-- For fiscal year 2006, the Company reported net income of $2.9
million and assets of $7.2 million, making the year its most
successful in its history. This equated to net income of $0.03
per common share, fully diluted, and a positive increase,
year-to-year, of $6.6 million. Its revenues reached $6,750,229 as
compared to $154,580 for the year ended September 30, 2005, an
increase of $6,595,649 or 4267%.
-- From its evolving Genesis Equity Partners program, an umbrella of
limited liability subsidiaries, the Company believes that it
could generate at least $2 million in profits from each Chinese
partner company. Such projected profits are based on the first
graduate of the revitalized program, Lotus Pharmaceuticals, Inc.
(OTCBB:LTUS) that actually produced profits far exceeding these
levels. Genesis projects it could add as many as six new partners
to its existing four contracts, and envisions profits possibly
reaching $20 million and assets of $30 million or more.
-- Management holds that forming a turnkey operation coupled with
sustainability and repeated success should convince the U.S.
investment community that Genesis is for real and deserves the
consistent support that would limit the current vagaries and
uncertainties of the Bulletin Board market place. The letter
concludes by stating that "management has reached the point that
it welcomes being judged by results and not promises."
na hoffentlich halten die auch was sie versprechen.dann könnten wir noch viel freude mit unserer aktie haben.
en bischen mehr information und interesse der anleger täte dem thread auch gut.
aber zumindest wird hier nicht som gezofft wie in vielen anderen threads, ist auch was wert.
also auf gehts genesis ab nach norden endlich mal!!
Danke Turbospeed für´s Reinstellen der News.
Na also. Scheint so, als ob es bei Genesis weiterhin aufwärts gehen würde. Langsam aber stettig.
Und mir isses auch lieber, es bleibt so, damit die ganzen Daytrader hier weg bleiben.
Besser kontinuierlich langsam aufwärts, als schnell hoch und wieder runter.
Gruß an alle Longies.
Na also. Scheint so, als ob es bei Genesis weiterhin aufwärts gehen würde. Langsam aber stettig.
Und mir isses auch lieber, es bleibt so, damit die ganzen Daytrader hier weg bleiben.
Besser kontinuierlich langsam aufwärts, als schnell hoch und wieder runter.
Gruß an alle Longies.
doppelter Boden/Unterstützung bei 0.12 Dollar
Bald wieder 0.2 Dollar?
MIND
News:
GENESIS TECHNOLOGY GROUP
Lotus CEO Announces Expansion Strategy to Reach China's Top Tier of Pharmaceuticals With Revenues Exceeding $100 Million
3/21/2007
BEIJING, Mar 21, 2007 (PrimeNewswire via COMTEX News Network) --
Lotus Pharmaceuticals, Inc. (OTCBB:LTUS) released an exchange between its CEO Dr. Liu Zhongyi and a Wall Street financial advisor, describing the Company's goal to rank among China's top pharmaceutical companies with annual revenues exceeding $100 million.
The discussion followed Lotus's obtaining initial financing of $3 million on February 12, 2007, and the program has already attracted more interest from U.S. funds that could enable Lotus to expand through acquisition and its well-performing R&D program.
http://www.stockhouse.com/news/news.asp?newsid=5003290&tick=…
GENESIS TECHNOLOGY GROUP
Lotus CEO Announces Expansion Strategy to Reach China's Top Tier of Pharmaceuticals With Revenues Exceeding $100 Million
3/21/2007
BEIJING, Mar 21, 2007 (PrimeNewswire via COMTEX News Network) --
Lotus Pharmaceuticals, Inc. (OTCBB:LTUS) released an exchange between its CEO Dr. Liu Zhongyi and a Wall Street financial advisor, describing the Company's goal to rank among China's top pharmaceutical companies with annual revenues exceeding $100 million.
The discussion followed Lotus's obtaining initial financing of $3 million on February 12, 2007, and the program has already attracted more interest from U.S. funds that could enable Lotus to expand through acquisition and its well-performing R&D program.
http://www.stockhouse.com/news/news.asp?newsid=5003290&tick=…
na ja hoffen wer mal das genesis davon profitieren kann als beiteiligter.jetzt noch en paar gute abschlüsse, gute quartalszahlen und wir dürften dann blad mal die 0,20 € mal wieder sehen.
warten wers ab was das jahr noch bringt.
ich glaube die Fa. ist gesund und das ist erst mal wichtig, dann kommt die kurssteigerung irgendwann von alleine.
etwas mehr interesse für einen meinungsaustausch hier wäre auch nett.
danke der bergruft für dein posting.
Antwort auf Beitrag Nr.: 28.427.613 von mindgames1001 am 22.03.07 11:32:28 ich hoffe dieses jahr noch auf 0,30 dollar
ich hoffe dieses jahr noch auf 0,30 dollar
Sieht ja ziemlich gut aus heute... 0,135€ und recht hohe Umsätze!!!
Hallo leute,
ist eigentlich noch jemand am Start
oder seid ihr alle ausgestiegen?
liebe Grüße
AlCamus
ist eigentlich noch jemand am Start
oder seid ihr alle ausgestiegen?
liebe Grüße
AlCamus
Genesis' Pharmaceutical Partner Releases Audited Annual Report with $4.1 Million in Net Profits
Wednesday April 18, 6:30 am ET
BEIJING, April 18, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) announced that its Chinese pharmaceutical partner yesterday released its 2006 audited annual report. Lotus Pharmaceuticals, Inc. (OTC BB:LTUS.OB - News) revealed gross revenues of $36 million, net profits of $4.1 million and net assets of $20.6 million.
Dr. Shaohua Tan, Genesis' Director headquartered in Beijing, also offered an update for the Genesis private-to-public program that operates under the name Genesis Equity Partners, LLC (GEP), a group of majority-owned subsidiaries, individually designated for each Chinese partner company. Among Dr. Tan's key comments were:
1. Lotus has shown good progress since becoming a GEP partner company
last March. GTEC owns 6.7 million LTUS common shares of the 50
million outstanding. Genesis maintains an active role in Lotus
operations and strategy, having appointed three members on its
board of directors, also serving in an ongoing consulting
capacity overseeing its U.S. office and activities.
2. Gold Horse International, Inc. (GHI) continues to advance to
public company status. Its official U.S. audit required an
updating through December 2006, which has now been completed by
Kabani & Company. GHI has moved into the late stages of the GEP
private-to-public program.
3. The other three GEP partner companies bear U.S. designations and
have entered the exacting U.S. auditing stage. China Environmental
Technologies, Oriental Health Beverages, and Sino Steel Structures
could produce significant profits and assets for Genesis, if
those Chinese companies' U.S. audits and legal due diligence
confirm internal reporting. With each company, Genesis would play
an active role in its management and strategy to attain its
goals and expansion.
4. The revised rules and regulations of the China Securities
Regulatory Commission (CSRC), invoked August-September 2006,
have placed a significant additional burden on GEP and its
competitors. While the full impact is still being determined,
it seems apparent that CSRC rulings have (a) increased the costs
and risks, (b) created additional steps with central government
involvement, and (c) delayed the process to complete the
private-to-public process. Dr. Tan closed by emphasizing that
"any future changes or revisions by the CSRC could have a major
impact on the GEP business model."
Wednesday April 18, 6:30 am ET
BEIJING, April 18, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) announced that its Chinese pharmaceutical partner yesterday released its 2006 audited annual report. Lotus Pharmaceuticals, Inc. (OTC BB:LTUS.OB - News) revealed gross revenues of $36 million, net profits of $4.1 million and net assets of $20.6 million.
Dr. Shaohua Tan, Genesis' Director headquartered in Beijing, also offered an update for the Genesis private-to-public program that operates under the name Genesis Equity Partners, LLC (GEP), a group of majority-owned subsidiaries, individually designated for each Chinese partner company. Among Dr. Tan's key comments were:
1. Lotus has shown good progress since becoming a GEP partner company
last March. GTEC owns 6.7 million LTUS common shares of the 50
million outstanding. Genesis maintains an active role in Lotus
operations and strategy, having appointed three members on its
board of directors, also serving in an ongoing consulting
capacity overseeing its U.S. office and activities.
2. Gold Horse International, Inc. (GHI) continues to advance to
public company status. Its official U.S. audit required an
updating through December 2006, which has now been completed by
Kabani & Company. GHI has moved into the late stages of the GEP
private-to-public program.
3. The other three GEP partner companies bear U.S. designations and
have entered the exacting U.S. auditing stage. China Environmental
Technologies, Oriental Health Beverages, and Sino Steel Structures
could produce significant profits and assets for Genesis, if
those Chinese companies' U.S. audits and legal due diligence
confirm internal reporting. With each company, Genesis would play
an active role in its management and strategy to attain its
goals and expansion.
4. The revised rules and regulations of the China Securities
Regulatory Commission (CSRC), invoked August-September 2006,
have placed a significant additional burden on GEP and its
competitors. While the full impact is still being determined,
it seems apparent that CSRC rulings have (a) increased the costs
and risks, (b) created additional steps with central government
involvement, and (c) delayed the process to complete the
private-to-public process. Dr. Tan closed by emphasizing that
"any future changes or revisions by the CSRC could have a major
impact on the GEP business model."
Antwort auf Beitrag Nr.: 28.870.045 von AlCamus am 17.04.07 21:47:16Hab heute meinen Bestand nochmal verdoppelt. Vom Chart hert ist der Aufwärtstrend in takt. Bin mir sicher, dass wir hier schon sehr bald andere Kurse sehe.
cu
cu
Wenn das bei Yahoo alles so stimmt, hat Genesis ein KGV von aktuell 5,4 und der Börsenwert von 13 Mio US$ entspricht nicht einmal der Lotus Beteiligung(6,3 Mio Aktien x 2,25 = 14 Mio US$).
Sieht also gut aus, nur das Interesse fehlt. Vielleicht entdecken das ja bald einige mehr...
Volumen steigt zumindest heute auch leicht an!
Sieht also gut aus, nur das Interesse fehlt. Vielleicht entdecken das ja bald einige mehr...
Volumen steigt zumindest heute auch leicht an!
Bid bei 0,12 € - Ask bei 0,124, letzter Kurs in FRF 0,121€
schaut so aus, als gehts jetzt wieder los...
schaut so aus, als gehts jetzt wieder los...
Ich habe auch mal wieder nachgelegt.
Den kommenden Anstieg will ich mir nicht engehen lassen
AlCamus
Den kommenden Anstieg will ich mir nicht engehen lassen
AlCamus
maydorn; depotaufnahme; kz 0,30
Antwort auf Beitrag Nr.: 28.952.679 von 123mexico am 23.04.07 13:52:41Hab mir heute auch mal welche ins Depot gelegt.....
Hoffe hier knallt das diese Woche richtig
Gruss
Hoffe hier knallt das diese Woche richtig
Gruss
Antwort auf Beitrag Nr.: 28.952.781 von malteser80 am 23.04.07 14:01:24das knallt heute schon!
Wegen der Maydorn-Aufnahme geht´s gerade hoch?
Da meldet der Laden seit nem halben Jahr einen Knaller nach dem anderen und es tut sich nicht sooo viel.
Kommt aber der Maydorn, dann..... will wieder alles aufspringen.
Naja ein bisschen PR schadet nicht. Hoffentlich kloppen die Daytrader den Kurs ein paar Tagen nicht gleich wieder in den Eimer....
Hat er zum Kursziel noch einen Zeithorizont genannt?
Da meldet der Laden seit nem halben Jahr einen Knaller nach dem anderen und es tut sich nicht sooo viel.
Kommt aber der Maydorn, dann..... will wieder alles aufspringen.
Naja ein bisschen PR schadet nicht. Hoffentlich kloppen die Daytrader den Kurs ein paar Tagen nicht gleich wieder in den Eimer....
Hat er zum Kursziel noch einen Zeithorizont genannt?
Antwort auf Beitrag Nr.: 28.953.639 von Eskobar69 am 23.04.07 15:01:04mittelfristig meine ich......
Antwort auf Beitrag Nr.: 28.954.208 von malteser80 am 23.04.07 15:34:28Jetzt ist es noch sehr güntig hier einzusteigen....
Mein Name ist zwar nicht NoggerT aber das merkt und sieht ein blinder das diese Rakete hier bald abgeht......
Mein Name ist zwar nicht NoggerT aber das merkt und sieht ein blinder das diese Rakete hier bald abgeht......
Der Tag war mal wieder klasse.
Es läuft alles sehr gut im Unternehmen. Es kommen gut
News und Maydorn bläst zu Kurszielen von 0,30
Bin gespannt wie es weitergeht, aber ich bin mir sicher
dass es erst der Anfang ist.
AlCamus
Es läuft alles sehr gut im Unternehmen. Es kommen gut
News und Maydorn bläst zu Kurszielen von 0,30
Bin gespannt wie es weitergeht, aber ich bin mir sicher
dass es erst der Anfang ist.
AlCamus
und es geht weiter
Schön wie die läuft. Auf der Umsatz heute ist nicht schlecht. Jetzt noch ne news und die 0,30 rücken in greifbare Nähe. 
Antwort auf Beitrag Nr.: 28.971.130 von loui2005 am 24.04.07 14:53:58 langsam langsam...nehmen wer erst mal gemächlich die 0,20 hürde das wird schwer genug.
dann langsam weiter.
wir brauchen hier keine zocker mehr wie letztes mal als sie fürchterlich abgeschmiert ist danach.
so wie s jetzt ist isses ok langsam aber stetig nach oben ohne die grossen zocker und daytrader
langsam langsam...nehmen wer erst mal gemächlich die 0,20 hürde das wird schwer genug.dann langsam weiter.
wir brauchen hier keine zocker mehr wie letztes mal als sie fürchterlich abgeschmiert ist danach.
so wie s jetzt ist isses ok langsam aber stetig nach oben ohne die grossen zocker und daytrader
Ja wer wird denn hier verkaufen,die Chancen sind grösser als je zuvor
Diejenigen, die jetzt verkaufen verstehe ich auch nicht. hier kann es jeden tag wieder gute News kommen. irgendwann steigen wir nachhaltig. Schaut euch doch nur die zahlen an. Ihr könnt doch alle lesen.
AlCamus
AlCamus
und ich kann nicht schreiben....sorry...gute news geben mein ich natürlich
Hallo @
Ist hier niemand???
Es läuft doch bestens!!
Es wird langsam aber sicher ein gutes Investment für mich.
Ist hier niemand???
Es läuft doch bestens!!
Es wird langsam aber sicher ein gutes Investment für mich.
Antwort auf Beitrag Nr.: 29.075.717 von Zipp20 am 30.04.07 18:05:53Hallo ich bin auch noch da!!
Ich glaube so langsam kommt die Wende und wir drehen nach oben.
Ich glaube so langsam kommt die Wende und wir drehen nach oben.
Antwort auf Beitrag Nr.: 29.075.717 von Zipp20 am 30.04.07 18:05:53natürlich sind wir hier.
Ich verfolge den Kursverlauf auch mit entspannter und guter Laune.
Jede Woche ein paar % und ich bin zufrieden.
Mein Ziel kurzfristig sind zumindest die 0,20€.
Danach werden wir weitersehen.
Wobei man ja nicht sofort wieder übertreiben soll.
Solang ab und zu gute News kommen und der Kurs sich hält ists ok
AlCamus
Ich verfolge den Kursverlauf auch mit entspannter und guter Laune.
Jede Woche ein paar % und ich bin zufrieden.
Mein Ziel kurzfristig sind zumindest die 0,20€.
Danach werden wir weitersehen.
Wobei man ja nicht sofort wieder übertreiben soll.
Solang ab und zu gute News kommen und der Kurs sich hält ists ok
AlCamus
Genesis Subject of Dutton Associates Research Report
4/30/2007
BOCA RATON, Fla., Apr 30, 2007 (PrimeNewswire via COMTEX News Network) --
Genesis Technology Group, Inc. (OTCBB:GTEC) announced that Dutton Associates has released a research report covering the Company.
Dutton Associates is one of the largest issuer-paid equity research firms in the United States and its investment performance is ranked comparable to that of the top Wall Street firms. Its analysts, primarily CFAs with over 20 years of experience at the major securities firms, are among the most experienced on Wall Street. Dutton Associates offers high-quality, independent, fundamental research on small cap public companies. For the research report and additional information, refer to www.duttonassociates.com.
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that partners with qualified Chinese companies to expand their domestic and international market opportunities. The customized private-to-public program seeks to tap in to Western capital markets to attain this goal. Commitment, dedication, and expertise are the key components to the Genesis "Mission Statement." It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined "partner companies." Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.net.
Safe Harbor Statement and Disclaimer
Certain statements set forth in this press release constitute "forward-looking statements". Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission. The capital and growth program, the Company's central profit center, has specific risks and liabilities. Followers of our business model must understand that, until the Chinese partner company officially reaches public company status and files its initial Form 8-K, a high degree of risk exists that the partner may not ever attain that status. While receipt of a significant equity position in these companies is contractual, Genesis still recognizes that such compensation is conditional on performance and specific deliverables.
This news release was distributed by PrimeNewswire, www.primenewswire.com
SOURCE: Genesis Technology Group, Inc.
Genesis Technology Group, Inc. Kenneth L. Clinton, President (561) 988-9880 Fax: (561) 988-9890 info@Genesis-China.net 7900 Glades Road, Suite 420 Boca Raton, Florida 33434 United States of America
(C) Copyright 2007 PrimeNewswire, Inc. All rights reserved.
4/30/2007
BOCA RATON, Fla., Apr 30, 2007 (PrimeNewswire via COMTEX News Network) --
Genesis Technology Group, Inc. (OTCBB:GTEC) announced that Dutton Associates has released a research report covering the Company.
Dutton Associates is one of the largest issuer-paid equity research firms in the United States and its investment performance is ranked comparable to that of the top Wall Street firms. Its analysts, primarily CFAs with over 20 years of experience at the major securities firms, are among the most experienced on Wall Street. Dutton Associates offers high-quality, independent, fundamental research on small cap public companies. For the research report and additional information, refer to www.duttonassociates.com.
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that partners with qualified Chinese companies to expand their domestic and international market opportunities. The customized private-to-public program seeks to tap in to Western capital markets to attain this goal. Commitment, dedication, and expertise are the key components to the Genesis "Mission Statement." It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined "partner companies." Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.net.
Safe Harbor Statement and Disclaimer
Certain statements set forth in this press release constitute "forward-looking statements". Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission. The capital and growth program, the Company's central profit center, has specific risks and liabilities. Followers of our business model must understand that, until the Chinese partner company officially reaches public company status and files its initial Form 8-K, a high degree of risk exists that the partner may not ever attain that status. While receipt of a significant equity position in these companies is contractual, Genesis still recognizes that such compensation is conditional on performance and specific deliverables.
This news release was distributed by PrimeNewswire, www.primenewswire.com
SOURCE: Genesis Technology Group, Inc.
Genesis Technology Group, Inc. Kenneth L. Clinton, President (561) 988-9880 Fax: (561) 988-9890 info@Genesis-China.net 7900 Glades Road, Suite 420 Boca Raton, Florida 33434 United States of America
(C) Copyright 2007 PrimeNewswire, Inc. All rights reserved.
Und hat jemand diesen Dutton Research Report und könnte "andeuten", was darin so zu Genesis geschrieben wird?
Antwort auf Beitrag Nr.: 29.118.301 von Eskobar69 am 03.05.07 19:36:21Das ist eine Ankündigung, aber noch kein Research-Report. Aber dieser Report wird folgen, sobald Dutton GTEC durchleuchtet hat. Ist aber als äusserst positiv zu einzustufen, dass sich Dutton GTEC "zur Brust" nimmt.
Die Entwicklung gefällt mir auch.
Denke es ist auf jeden Fall positiv zu werten.
schönen Abend
AlCamus
Denke es ist auf jeden Fall positiv zu werten.
schönen Abend
AlCamus
Antwort auf Beitrag Nr.: 29.118.597 von turbospeedy am 03.05.07 19:55:34Sorry, habe mich beim Überflug (lesen) der Zeilen geirrt. Es gibt natürlich bereits den DUTTON-Report!
Ein kleiner Auszug daraus (Im Original übrigens sehr schön aufbereitet):
Rating: Speculative Buy
Basis for Rating
We are initiating coverage of Genesis Technology Group Inc. (Genesis) with a Speculative Buy rating. The Company is
principally engaged in providing consulting services and turnkey solutions for Chinese small and mid-sized companies that
seek to enter the Western markets for capital to finance growth. The major breakthrough for Genesis was in mid-2006
when the Company established Genesis Equity Partners LLC (GEP) to consolidate and refine its operations in China.
Through its majority-owned subsidiaries, each designated as a GEP limited liability company for the specific Chinese
contract partner, Genesis demonstrated its capability by transforming Lotus Pharmaceuticals from a Chinese private
enterprise to a U.S. publicly listed company.
In our view, the GEP business model is a low cost, feasible, and profitable model that would enable Genesis to benefit
from the huge business opportunities in China, which has emerged as the world’s fourth largest and fastest growing major
economy. By taking advantages of the inefficient capital markets in China and leveraging its established connections,
information, and skills, Genesis has been able to identify quality companies with good growth potential but which are
starved for capital to finance growth to join its GEP private-to-public program. So far, Genesis has completed the deal for
Lotus Pharmaceuticals, with Gold Horse pending for completion and signed contracts for three other companies.
Contributions from these companies will be the major source of revenue and net income in the fiscal years 2007 and 2008,
and will establish a more solid track record to attract potential clients.
In our earnings forecasts, we project the Company’s fiscal year 2007 net income to increase 61.1% to $4.7 million from
$2.9 million in fiscal year 2006. Net income in fiscal year 2008 is expected to increase a further 60.6% to $7.5 million.
Diluted EPS should be at $0.04 for fiscal year 2007 and $0.06 for fiscal year 2008. However, our forecasts are based on
the key assumptions that the Company will be able to complete two GEP projects in fiscal year 2007 and three projects in
fiscal year 2008, and most importantly, will be able to register and sell a large portion of the restricted shares received
from its client companies for the services rendered.
....
hier der Link (Gasamt 26 Seiten/PDF)
http://www.jmdutton.com/research/gtec/reports/gtec_report_04…
Ein kleiner Auszug daraus (Im Original übrigens sehr schön aufbereitet):
Rating: Speculative Buy
Basis for Rating
We are initiating coverage of Genesis Technology Group Inc. (Genesis) with a Speculative Buy rating. The Company is
principally engaged in providing consulting services and turnkey solutions for Chinese small and mid-sized companies that
seek to enter the Western markets for capital to finance growth. The major breakthrough for Genesis was in mid-2006
when the Company established Genesis Equity Partners LLC (GEP) to consolidate and refine its operations in China.
Through its majority-owned subsidiaries, each designated as a GEP limited liability company for the specific Chinese
contract partner, Genesis demonstrated its capability by transforming Lotus Pharmaceuticals from a Chinese private
enterprise to a U.S. publicly listed company.
In our view, the GEP business model is a low cost, feasible, and profitable model that would enable Genesis to benefit
from the huge business opportunities in China, which has emerged as the world’s fourth largest and fastest growing major
economy. By taking advantages of the inefficient capital markets in China and leveraging its established connections,
information, and skills, Genesis has been able to identify quality companies with good growth potential but which are
starved for capital to finance growth to join its GEP private-to-public program. So far, Genesis has completed the deal for
Lotus Pharmaceuticals, with Gold Horse pending for completion and signed contracts for three other companies.
Contributions from these companies will be the major source of revenue and net income in the fiscal years 2007 and 2008,
and will establish a more solid track record to attract potential clients.
In our earnings forecasts, we project the Company’s fiscal year 2007 net income to increase 61.1% to $4.7 million from
$2.9 million in fiscal year 2006. Net income in fiscal year 2008 is expected to increase a further 60.6% to $7.5 million.
Diluted EPS should be at $0.04 for fiscal year 2007 and $0.06 for fiscal year 2008. However, our forecasts are based on
the key assumptions that the Company will be able to complete two GEP projects in fiscal year 2007 and three projects in
fiscal year 2008, and most importantly, will be able to register and sell a large portion of the restricted shares received
from its client companies for the services rendered.
....
hier der Link (Gasamt 26 Seiten/PDF)
http://www.jmdutton.com/research/gtec/reports/gtec_report_04…
kann mir mal einer erklären ob das nun gut oder schlecht oder für ggetech was bringt.
mal sehen wo wir nach den quartalszahlen stehen.
wann kommen den die nächsten?
mal sehen wo wir nach den quartalszahlen stehen.
wann kommen den die nächsten?
Na wenn die Einnahmen in 2007 und 2008 jeweils um ca. 60 Prozent ansteigen, ist das schon mal nicht schlecht.
Die Frage ist nur, was zum Schluss an Gewinn liegen bleibt.
Aber das hört sich ja nicht übel an....
Die Frage ist nur, warum dann heute hier wieder einige (ungeduldige) in Frankfurt ihre Anteile verschenken....
Die Frage ist nur, was zum Schluss an Gewinn liegen bleibt.
Aber das hört sich ja nicht übel an....
Die Frage ist nur, warum dann heute hier wieder einige (ungeduldige) in Frankfurt ihre Anteile verschenken....
Antwort auf Beitrag Nr.: 29.190.264 von Eskobar69 am 07.05.07 16:31:51 und es wird weiter verschenkt. es geht langsam wieder abwärts. verdammter mist hier. 
und es wird weiter verschenkt. es geht langsam wieder abwärts. verdammter mist hier. 
Solange hier über BB-"Empfehlungen" nur "Daytrader" investieren, kanns nicht hoch gehen.
Hier braucht man Sitzfleisch.
Zocker, die hier in 10 Tagen 200% machen wollen sollen woanders investieren. Alle Longies sind herzlich willkommen.
Man ich versteh die Typen nicht, die jetzt ihre Shares in Frankfurt wieder verschenken. Naja jeder muss selber wissen, wann er verklauft bzw. kauft.
Bevor das missverstanden wird, ich hab jetzt nicht dich, Petrohunter, gemeint.
Hier braucht man Sitzfleisch.
Zocker, die hier in 10 Tagen 200% machen wollen sollen woanders investieren. Alle Longies sind herzlich willkommen.
Man ich versteh die Typen nicht, die jetzt ihre Shares in Frankfurt wieder verschenken. Naja jeder muss selber wissen, wann er verklauft bzw. kauft.
Bevor das missverstanden wird, ich hab jetzt nicht dich, Petrohunter, gemeint.
Antwort auf Beitrag Nr.: 29.247.356 von Eskobar69 am 10.05.07 11:35:13
mich kannst ja auch nicht meinen bin ja schon ultralong dabei und versteh selber nicht wer hier seine aktien für en apfel und en ei hergibt.
die machen fast allesamt verluste obwohl hier abwarten erst mal sinnvoller wäre.
versteh das mal einer.
na ja frustrierend aber so ist halt börse.
wir werden wohl wieder mal auf sehr gute quartalszahlen und news warten müssen, bevor hier nachhaltig was passiert.
von steigender tendenz können wer uns bis dahin erst mal verabschieden.
hoffentlich katapultieren uns diese zocker nicht wieder auf die alten tiefen zurück.
dachte unter 0,10 fallen wer nicht mehr. hab mich wohl gewaltig getäuscht.
enttäuschend im moment.
mich kannst ja auch nicht meinen bin ja schon ultralong dabei und versteh selber nicht wer hier seine aktien für en apfel und en ei hergibt.die machen fast allesamt verluste obwohl hier abwarten erst mal sinnvoller wäre.
versteh das mal einer.
na ja frustrierend
aber so ist halt börse.wir werden wohl wieder mal auf sehr gute quartalszahlen und news warten müssen, bevor hier nachhaltig was passiert.
von steigender tendenz können wer uns bis dahin erst mal verabschieden.
hoffentlich katapultieren uns diese zocker nicht wieder auf die alten tiefen zurück.
dachte unter 0,10 fallen wer nicht mehr. hab mich wohl gewaltig getäuscht.
enttäuschend im moment.
Wow was ist denn heute los.
So eine Angst
So eine Angst
news NEW YORK, May 25 (newratings.com) - Analysts at JM Dutton reiterate their "speculative buy" rating on Genesis Technology Group Inc (ticker: GTEC). The target price is set to $0.22.
In a research note published this morning, the analysts mention that while Lotus Pharmaceuticals, the company’s partner, reported its 1Q revenue growth at 26.73%, its operating income declined by 2.3% in the quarter due to the significantly increased operating expenses. According to the analysts, Genesis Technology’s performance going forward is unlikely to be significantly impacted by its partner’s 1Q results. The company is likely to complete two of its five ongoing projects in 2007 and the remaining in 2008, JM Dutton adds.
Recommend this article to a friend
05/23/07 Genesis Technology "speculative buy" JM Dutton & Associates
05/18/07 Genesis Technology "speculative buy" JM Dutton & Associates
Antwort auf Beitrag Nr.: 29.496.367 von Tiggercat am 28.05.07 09:40:46
NEW YORK, 25. Mai (newratings.com) - Analytiker an JM Dutton reiterieren ihre Bewertung „des spekulativen Kaufes“ auf Genese-Technologie-Gruppe Inc. (Börsentelegraph: GTEC). Der Richtpreis wird bis $0.22 eingestellt.
In der Forschung veröffentlichte eine Anmerkung heute morgen, die Analytikererwähnung, die, während Lotos-pharmazeutische Produkte, der Partner der Firma, über sein Einkommen 1Q Wachstum bei 26.73% berichteten, sein Betriebseinkommen um 2.3% im Viertel wegen der erheblich erhöhten Betriebskosten sank. Nach Ansicht der Analytiker ist die Leistung der Genese-Technologie, die vorwärts geht, unwahrscheinlich, durch Resultate 1Q seines Partners erheblich ausgewirkt zu werden. Die Firma ist wahrscheinlich, zwei seiner fünf fortwährenden Projekte 2007 durchzuführen und das restliche 2008, JM Dutton fügt hinzu.
Diesen Artikel einem Freund empfehlen
05/23/07 Genese-Technologie „spekulativer Kauf“ JM Dutton u. Teilnehmer
05/18/07 Genese-Technologie „spekulativer Kauf“ JM Dutton u. Teilnehmer
NEW YORK, 25. Mai (newratings.com) - Analytiker an JM Dutton reiterieren ihre Bewertung „des spekulativen Kaufes“ auf Genese-Technologie-Gruppe Inc. (Börsentelegraph: GTEC). Der Richtpreis wird bis $0.22 eingestellt.
In der Forschung veröffentlichte eine Anmerkung heute morgen, die Analytikererwähnung, die, während Lotos-pharmazeutische Produkte, der Partner der Firma, über sein Einkommen 1Q Wachstum bei 26.73% berichteten, sein Betriebseinkommen um 2.3% im Viertel wegen der erheblich erhöhten Betriebskosten sank. Nach Ansicht der Analytiker ist die Leistung der Genese-Technologie, die vorwärts geht, unwahrscheinlich, durch Resultate 1Q seines Partners erheblich ausgewirkt zu werden. Die Firma ist wahrscheinlich, zwei seiner fünf fortwährenden Projekte 2007 durchzuführen und das restliche 2008, JM Dutton fügt hinzu.
Diesen Artikel einem Freund empfehlen
05/23/07 Genese-Technologie „spekulativer Kauf“ JM Dutton u. Teilnehmer
05/18/07 Genese-Technologie „spekulativer Kauf“ JM Dutton u. Teilnehmer
Antwort auf Beitrag Nr.: 29.496.385 von Tiggercat am 28.05.07 09:45:29da kann man aber wirklich nur die "Augen verdrehen"
wie Du da unleserlich uebersetztes reinstellst!
wie Du da unleserlich uebersetztes reinstellst!
Antwort auf Beitrag Nr.: 29.247.356 von Eskobar69 am 10.05.07 11:35:13 mich kannst nicht meinen esko... ich sitz das hier aus bis das teil auf 1.- € steht, bin schon seit 2 jahren long also ...mich bringt hier so schnell keiner raus
mich kannst nicht meinen esko... ich sitz das hier aus bis das teil auf 1.- € steht, bin schon seit 2 jahren long also ...mich bringt hier so schnell keiner raus
Antwort auf Beitrag Nr.: 29.535.433 von schwechater am 30.05.07 10:00:04 na ja lieber unleserlich und positiv als leserlich und negativ ggg
na ja lieber unleserlich und positiv als leserlich und negativ ggg
Antwort auf Beitrag Nr.: 29.596.030 von Petrohunter am 02.06.07 19:14:05 einer der informationsreichsten threads den es hier gibt
na ja wenn die aktie steigen sollte werden hier wieder alle reinströmen.
schade eigentlich.
einer der informationsreichsten threads den es hier gibt na ja wenn die aktie steigen sollte werden hier wieder alle reinströmen.
schade eigentlich.
doppelter Boden bei 0.1 Dollar und dann up?
mal sehen....
MIND
Antwort auf Beitrag Nr.: 29.822.663 von Petrohunter am 11.06.07 15:46:04
@reiferer: die +40% der Woche lassen sich doch sehen oder?
@reiferer: die +40% der Woche lassen sich doch sehen oder?
es gibt heute News...
Antwort auf Beitrag Nr.: 30.849.062 von DerBergderruft am 25.07.07 19:25:15sorry... ich meinte es gab News.... aber es bewegt sich nichts...
Antwort auf Beitrag Nr.: 30.850.478 von DerBergderruft am 25.07.07 20:56:54wann hat sich hier mal was BEWEGT
Antwort auf Beitrag Nr.: 30.850.478 von DerBergderruft am 25.07.07 20:56:54Wenn´s "News" gibt bzw. gab, hättste diese wenigstens hier reinstellen können, damit man weiss, wovon du sprichst.
Vielleicht kennen diese News ja noch nicht alle.
Vielleicht kennen diese News ja noch nicht alle.
Antwort auf Beitrag Nr.: 30.849.062 von DerBergderruft am 25.07.07 19:25:15schon wieder News, sollte man hier einsteigen?
Genesis Technology Group Announces Position in Gold Horse International
BOCA RATON, Fla., July 26, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTCBB:GTEC) announced its equity ownership in Gold Horse International, Inc., which completed a merger in late June with Speedhaul Holdings, Inc., and attained public company status on the OTC Bulletin Board. As a result, management anticipates that Genesis will show a profit for its fiscal year ended September 30, 2007.
Currently, Genesis owns 8.5 million shares in Gold Horse International (OTCBB:SPEH) and 6.7 million shares in Lotus Pharmaceuticals, Inc (OTCBB:LTUS). With an additional four Chinese companies under contract and at various stages of its program, Genesis could earn a significant equity stake in each partner company upon attaining public company status.
Gold Horse was the second partner company in the trailing nine months to complete the private-to-public program. "Gold Horse's success should place Genesis in a profitable position for the fiscal year," predicted management. Genesis maintains an active role in Gold Horse's management and business activities, including the assignment of Western directors to assist the company in executing its expanded business model.
Mr. Yang Lian Kuan, Gold Horse Chairman and Chief Executive Office, remarked from Hohhot, Inner Mongolia: "We are proud that Gold Horse has achieved public company status. The professionalism and dedication of the Genesis team proved unwavering, and we are confident that our collective efforts will prove greatly profitable. Gold Horse is a dynamic company in one of the fastest growing regions in all of China. In the coming years, we believe that the investing public will give enthusiastic support to Gold Horse."
For over 18 months, Genesis had worked with Gold Horse to attain OTC Bulletin Board status. Kabani & Company of Los Angeles completed the U.S. audit. Both Genesis and Gold Horse have been encouraged by the performance of another publicly listed company, China Housing and Land Development, Inc. (OTCBB:CHLN), which has a current market cap exceeding $100 million.
Source: PrimeNewswire (July 26, 2007 - 5:30 AM EST)
Genesis Technology Group Announces Position in Gold Horse International
BOCA RATON, Fla., July 26, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTCBB:GTEC) announced its equity ownership in Gold Horse International, Inc., which completed a merger in late June with Speedhaul Holdings, Inc., and attained public company status on the OTC Bulletin Board. As a result, management anticipates that Genesis will show a profit for its fiscal year ended September 30, 2007.
Currently, Genesis owns 8.5 million shares in Gold Horse International (OTCBB:SPEH) and 6.7 million shares in Lotus Pharmaceuticals, Inc (OTCBB:LTUS). With an additional four Chinese companies under contract and at various stages of its program, Genesis could earn a significant equity stake in each partner company upon attaining public company status.
Gold Horse was the second partner company in the trailing nine months to complete the private-to-public program. "Gold Horse's success should place Genesis in a profitable position for the fiscal year," predicted management. Genesis maintains an active role in Gold Horse's management and business activities, including the assignment of Western directors to assist the company in executing its expanded business model.
Mr. Yang Lian Kuan, Gold Horse Chairman and Chief Executive Office, remarked from Hohhot, Inner Mongolia: "We are proud that Gold Horse has achieved public company status. The professionalism and dedication of the Genesis team proved unwavering, and we are confident that our collective efforts will prove greatly profitable. Gold Horse is a dynamic company in one of the fastest growing regions in all of China. In the coming years, we believe that the investing public will give enthusiastic support to Gold Horse."
For over 18 months, Genesis had worked with Gold Horse to attain OTC Bulletin Board status. Kabani & Company of Los Angeles completed the U.S. audit. Both Genesis and Gold Horse have been encouraged by the performance of another publicly listed company, China Housing and Land Development, Inc. (OTCBB:CHLN), which has a current market cap exceeding $100 million.
Source: PrimeNewswire (July 26, 2007 - 5:30 AM EST)
Antwort auf Beitrag Nr.: 30.857.972 von Q-Tipp am 26.07.07 12:54:36seit mehrere Monaten scheint sich Genesis sich auf ein Niveau on ca. 0.12 us bis 0,15 usd einzupendeln....
trotz aller guten News und der sehr niedrigen MK von ca. 7,8 Mio. euro...kommt einfach kein Leben rein..
Die Durststrecke ist einfach zu lang..und die Amis lassen den Kurs einfach nicht nach oben....
Ich weiss nicht wenn ein Umdenken kommt....
deshalb kann man sich derzeit nur zwischen Kursen von 0,071 euro - 0,085 euro bis ev. 0,091 euro positionieren und Bewegungen ab 0,115 zum Traden nutzen...
irgendwann sollte es nach oben gehen...
In einem USA-thread wird nur sporadisch über Genesis Tech geredet, wer will kann hier etwas darüber lesen..
http://ragingbull.quote.com/mboard/boards.cgi?board=BB:GTEC
Auch News helfen nicht weiter derzeit...und obwohl die Aktie in den letzen Tagen von einigen BB´s in den USA mehrfach erwähnt wurde:
hier mal einige Erwähnungen im Juli 2007:
News Releases: Results: 1 - 10 of 21 More
Release Date / Time (EST)
SmallCapStockAnalyst.com: nCoat Subsidiary HPC Integrates Performance Coatings Into Import Market 7/27/2007 8:58:46 AM
TraderGains: Today`s news - stocks on watch & more!! (OTCBB:MGEN) (OTCBB:GTEC), (OTCBB:SVSO), (OTC:ONCO), (OTC:PGPM) July 26, 2007 7/26/2007 10:42:08 AM
TheSUBWAY.com Inc.: TheSUBWAY.coms Stock Market Standouts List for Thursday, July 26, 2007: 7/26/2007 8:50:36 AM
TheSUBWAY.com Inc.: TheSUBWAY.coms Early Stock Market Alerts for Thursday, July 26, 2007: 7/26/2007 8:44:26 AM
Early Alert Small Cap Trade Opportunity for Thursday, July 26, 2007: GTEC Adding Partner Companies for Profitability! 7/26/2007 8:40:34 AM
Morning Call Companies on the Move for Thursday, July 26, 2007: GTEC Partner Projects Sales Exceeding $50 Million! 7/26/2007 8:35:50 AM
Genesis Technology Group Announces Position in Gold Horse International 7/26/2007 6:30:29 AM
Genesis Partner Lotus Pharmaceuticals Forecasts Sales Exceeding $50 Million From Catalog of Current and Future Drugs 7/25/2007 9:57:16 AM
FocusStockReport.com: Breaking Headlines from Gemini Explorations, Inc. (OTCBB: GXPI) 7/17/2007 5:14:22 AM
Traders Nation: Rule your own nation: (otc: CYPW), (otc: TENF), (otc: SHMM), and (bb: GTEC) 7/13/2007 12:51:59 PM
Summary
Genesis Technology Group is a business development firm that fosters bilateral commerce between companies in the United States and Europe with those in China. Genesis has created successful profit centers in product development, manufacturing, distribution, joint ventures and operational services. Genesis has established effective working relationships with various governmental agencies, public institutions, and private industries in China at both national and provincial levels.
trotz aller guten News und der sehr niedrigen MK von ca. 7,8 Mio. euro...kommt einfach kein Leben rein..
Die Durststrecke ist einfach zu lang..und die Amis lassen den Kurs einfach nicht nach oben....
Ich weiss nicht wenn ein Umdenken kommt....
deshalb kann man sich derzeit nur zwischen Kursen von 0,071 euro - 0,085 euro bis ev. 0,091 euro positionieren und Bewegungen ab 0,115 zum Traden nutzen...
irgendwann sollte es nach oben gehen...
In einem USA-thread wird nur sporadisch über Genesis Tech geredet, wer will kann hier etwas darüber lesen..
http://ragingbull.quote.com/mboard/boards.cgi?board=BB:GTEC
Auch News helfen nicht weiter derzeit...und obwohl die Aktie in den letzen Tagen von einigen BB´s in den USA mehrfach erwähnt wurde:
hier mal einige Erwähnungen im Juli 2007:
News Releases: Results: 1 - 10 of 21 More
Release Date / Time (EST)
SmallCapStockAnalyst.com: nCoat Subsidiary HPC Integrates Performance Coatings Into Import Market 7/27/2007 8:58:46 AM
TraderGains: Today`s news - stocks on watch & more!! (OTCBB:MGEN) (OTCBB:GTEC), (OTCBB:SVSO), (OTC:ONCO), (OTC:PGPM) July 26, 2007 7/26/2007 10:42:08 AM
TheSUBWAY.com Inc.: TheSUBWAY.coms Stock Market Standouts List for Thursday, July 26, 2007: 7/26/2007 8:50:36 AM
TheSUBWAY.com Inc.: TheSUBWAY.coms Early Stock Market Alerts for Thursday, July 26, 2007: 7/26/2007 8:44:26 AM
Early Alert Small Cap Trade Opportunity for Thursday, July 26, 2007: GTEC Adding Partner Companies for Profitability! 7/26/2007 8:40:34 AM
Morning Call Companies on the Move for Thursday, July 26, 2007: GTEC Partner Projects Sales Exceeding $50 Million! 7/26/2007 8:35:50 AM
Genesis Technology Group Announces Position in Gold Horse International 7/26/2007 6:30:29 AM
Genesis Partner Lotus Pharmaceuticals Forecasts Sales Exceeding $50 Million From Catalog of Current and Future Drugs 7/25/2007 9:57:16 AM
FocusStockReport.com: Breaking Headlines from Gemini Explorations, Inc. (OTCBB: GXPI) 7/17/2007 5:14:22 AM
Traders Nation: Rule your own nation: (otc: CYPW), (otc: TENF), (otc: SHMM), and (bb: GTEC) 7/13/2007 12:51:59 PM
Summary
Genesis Technology Group is a business development firm that fosters bilateral commerce between companies in the United States and Europe with those in China. Genesis has created successful profit centers in product development, manufacturing, distribution, joint ventures and operational services. Genesis has established effective working relationships with various governmental agencies, public institutions, and private industries in China at both national and provincial levels.
Antwort auf Beitrag Nr.: 30.853.601 von Eskobar69 am 26.07.07 08:44:11sorry... manchmal wird´s langweilig gute News reinzustellen die dem Kurs auch nicht weiterhelfen...
Offenbar ist die Zeit aktuell nicht reif für eine Kursrally... aber irgendwann sollte sie schon kommen...
manche brauchen wohl etwas länger...
Zurzeit bin ich nicht investiert, werde es wohl in den nächsten Tagen mal versuchen, sofern mir jemand seine günstigen Kurse abgibt..
Offenbar ist die Zeit aktuell nicht reif für eine Kursrally... aber irgendwann sollte sie schon kommen...
manche brauchen wohl etwas länger...
Zurzeit bin ich nicht investiert, werde es wohl in den nächsten Tagen mal versuchen, sofern mir jemand seine günstigen Kurse abgibt..
Taxe überall 0.07€,zudem Ruhe hier...vor dem Sturm?!
MIND
MIND
Genesis Partner, Lotus Pharmaceuticals, Reports $21 Million in Revenues and $4.1 Million in Net Profits in Quarterly Filing
Friday August 17, 6:30 am ET
BOCA RATON, Fla., Aug. 17, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) announced that its partner company, Lotus Pharmaceuticals, Inc. (OTC BB:LTUS.OB - News), released its second quarter results, with revenues topping $21 million, net profits of $4.1 million, and net assets of $17 million.
Mr. Adam Wasserman, Lotus Chief Financial Officer, reported: ``Total revenues for the six months ended June 30, 2007 were $21,095,000 as compared to total revenues of $16,047,000 for the six months ended June 30, 2006, an increase of $5,048,000 or approximately 31.5%. Lotus' working capital position increased $4,783,000 to $13,429,000 at June 30, 2007 from $8,646,000 at December 31, 2006.''
Dr. Shaohua Tan, Genesis Director in Beijing, observed: ``Lotus seems to go from strength-to-strength. Just six weeks ago, Gold Horse International (OTC BB:SPEH.OB - News) joined Lotus as a graduate from our private-to-public program. We are hopeful that a third Chinese partner company, prominent in environmental technologies, will join these alumni as a new U.S. public company before the end of Genesis' current fiscal year.''
ADVERTISEMENT
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that partners with qualified Chinese companies to expand their domestic and international market opportunities. The customized private-to-public program seeks to tap in to Western capital markets to attain this goal. Commitment, dedication, and expertise are the key components to the Genesis ``Mission Statement.'' It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined ``partner companies.'' Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.
Friday August 17, 6:30 am ET
BOCA RATON, Fla., Aug. 17, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) announced that its partner company, Lotus Pharmaceuticals, Inc. (OTC BB:LTUS.OB - News), released its second quarter results, with revenues topping $21 million, net profits of $4.1 million, and net assets of $17 million.
Mr. Adam Wasserman, Lotus Chief Financial Officer, reported: ``Total revenues for the six months ended June 30, 2007 were $21,095,000 as compared to total revenues of $16,047,000 for the six months ended June 30, 2006, an increase of $5,048,000 or approximately 31.5%. Lotus' working capital position increased $4,783,000 to $13,429,000 at June 30, 2007 from $8,646,000 at December 31, 2006.''
Dr. Shaohua Tan, Genesis Director in Beijing, observed: ``Lotus seems to go from strength-to-strength. Just six weeks ago, Gold Horse International (OTC BB:SPEH.OB - News) joined Lotus as a graduate from our private-to-public program. We are hopeful that a third Chinese partner company, prominent in environmental technologies, will join these alumni as a new U.S. public company before the end of Genesis' current fiscal year.''
ADVERTISEMENT
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that partners with qualified Chinese companies to expand their domestic and international market opportunities. The customized private-to-public program seeks to tap in to Western capital markets to attain this goal. Commitment, dedication, and expertise are the key components to the Genesis ``Mission Statement.'' It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined ``partner companies.'' Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.
Genesis Technology Group Releases Third Quarterly Report Showing Net Assets of $7.6 Million, An Increase of 47.5 Percent
Tuesday August 21, 6:30 am ET
BOCA RATON, Fla., Aug. 21, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) has released its third quarterly report for the period ended June 30, 2007. Net assets were approximately $7,608,000 compared to $5,221,000 on September 30, 2006, an increase of 45.7 percent.
CFO Adam Wasserman summarized: ``For the nine months ended June 30, 2007, we reported revenues of $3,035,000 as compared to $13,333 for the nine months ended June 30, 2006 which was attributable to a Share Exchange Agreement closed on June 29, 2007 by Speedhaul Holdings, Inc., Inc., a publicly-trading company (OTC BB:SPEH.OB - News), whereby GEP, our 51 percent-owned subsidiary, received 16,750,000 restricted common shares of SPEH for services performed in helping Gold Horse International and the Jin Ma Companies facilitate the merger with SPEH and for other business development services. For the nine months ended June 30, 2007, we reported net losses of $1,763,459 as compared to net income of $308,800 for the nine months ended June 30, 2006. At June 30, 2007, our net assets were approximately $7,608,000 compared to $5,221,000 at September 30, 2006, an increase of 45.7 percent.''
CEO Gary L. Wolfson added: ``Our immediate focus is completing the third private-to-public program for another Chinese partner company. If we can achieve this success in the coming six weeks, Genesis could boast of completing three such transformations in a 12-month period, quite an achievement. Genesis partner companies, attaining public company status in the U.S., would be Lotus Pharmaceuticals (OTC BB:LTUS.OB - News), Gold Horse International, and the new Green Power Technologies. Our current business model, although subject to burdensome regulations both in the U.S. and China, is effective and rewarding.''
ADVERTISEMENT
click here
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that partners with qualified Chinese companies to expand their domestic and international market opportunities. The customized private-to-public program seeks to tap in to Western capital markets to attain this goal. Commitment, dedication, and expertise are the key components to the Genesis ``Mission Statement.'' It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined ``partner companies.'' Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.net.
Safe Harbor Statement and Disclaimer
Certain statements set forth in this press release constitute ``forward-looking statements''. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words ``estimate'', ``project'', ``intend'', ``forecast'', ``anticipate'', ``plan'', ``planning'', ``expect'', ``believe'', ``will likely'', ``should'', ``could'', ``would'', ``may'' or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission. The capital and growth program, the Company's central profit center, has specific risks and liabilities. Followers of our business model must understand that, until the Chinese partner company officially reaches public company status and files its initial Form 8-K, a high degree of risk exists that the partner may not ever attain that status. While receipt of a significant equity position in these companies is contractual, Genesis still recognizes that such compensation is conditional on performance and specific deliverables.
Tuesday August 21, 6:30 am ET
BOCA RATON, Fla., Aug. 21, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) has released its third quarterly report for the period ended June 30, 2007. Net assets were approximately $7,608,000 compared to $5,221,000 on September 30, 2006, an increase of 45.7 percent.
CFO Adam Wasserman summarized: ``For the nine months ended June 30, 2007, we reported revenues of $3,035,000 as compared to $13,333 for the nine months ended June 30, 2006 which was attributable to a Share Exchange Agreement closed on June 29, 2007 by Speedhaul Holdings, Inc., Inc., a publicly-trading company (OTC BB:SPEH.OB - News), whereby GEP, our 51 percent-owned subsidiary, received 16,750,000 restricted common shares of SPEH for services performed in helping Gold Horse International and the Jin Ma Companies facilitate the merger with SPEH and for other business development services. For the nine months ended June 30, 2007, we reported net losses of $1,763,459 as compared to net income of $308,800 for the nine months ended June 30, 2006. At June 30, 2007, our net assets were approximately $7,608,000 compared to $5,221,000 at September 30, 2006, an increase of 45.7 percent.''
CEO Gary L. Wolfson added: ``Our immediate focus is completing the third private-to-public program for another Chinese partner company. If we can achieve this success in the coming six weeks, Genesis could boast of completing three such transformations in a 12-month period, quite an achievement. Genesis partner companies, attaining public company status in the U.S., would be Lotus Pharmaceuticals (OTC BB:LTUS.OB - News), Gold Horse International, and the new Green Power Technologies. Our current business model, although subject to burdensome regulations both in the U.S. and China, is effective and rewarding.''
ADVERTISEMENT
click here
About Genesis Technology Group, Inc.
Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that partners with qualified Chinese companies to expand their domestic and international market opportunities. The customized private-to-public program seeks to tap in to Western capital markets to attain this goal. Commitment, dedication, and expertise are the key components to the Genesis ``Mission Statement.'' It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined ``partner companies.'' Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.net.
Safe Harbor Statement and Disclaimer
Certain statements set forth in this press release constitute ``forward-looking statements''. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words ``estimate'', ``project'', ``intend'', ``forecast'', ``anticipate'', ``plan'', ``planning'', ``expect'', ``believe'', ``will likely'', ``should'', ``could'', ``would'', ``may'' or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission. The capital and growth program, the Company's central profit center, has specific risks and liabilities. Followers of our business model must understand that, until the Chinese partner company officially reaches public company status and files its initial Form 8-K, a high degree of risk exists that the partner may not ever attain that status. While receipt of a significant equity position in these companies is contractual, Genesis still recognizes that such compensation is conditional on performance and specific deliverables.
langsam aber sicher wird es hier sicher wieder nach oben gehen
Genesis Partner Announces New Contracts of Nearly $10 Million
Wednesday August 29, 6:30 am ET
BOCA RATON, Fla., Aug. 29, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) announced that two new building projects have been started by Gold Horse International. These Western China projects total nearly $10 million and should yield profits of about $1,750,000, according to management.
Mr. Yang Lian Kuan, Chairman and CEO of Gold Horse, also confirmed that Adam Wasserman, Chief Financial Officer, shall arrive in China soon after Labor Day to assist in the completion of the Company's 2007 annual report. This audited financial review, to be filed as 10-KSB with the S.E.C., is being performed by Kabani & Company of Los Angeles, California. ``We are confident that our shareholders will be impressed by the Company's performance over the past 12 months,'' predicted Mr. Yang. Currently, Genesis owns 8.5 million shares in Gold Horse International (OTC BB:SPEH.OB - News), which achieved public company status in late June, having progressed through the Genesis private-to-public, reverse merger program.
ADVERTISEMENT
Gold Horse was the second partner company in the trailing nine months to complete this program. Genesis maintains an active role in Gold Horse's management and business activities, including the assignment of Western directors to assist the company in executing its expanded business model.
Both Genesis and Gold Horse have been encouraged by the performance of another publicly listed company, China Housing and Land Development, Inc., which has a current market cap exceeding $100 million.
About Gold Horse International, Inc.
Gold Horse International, Inc., together with its subsidiaries, is an engineering and construction company that offers general contracting, construction management and design-building services to private clients and public agencies. Regarded as one of China's safest contractors in Western China, the Company's primary objective is to develop, execute, and maintain projects on schedule, within budget, and with excellence. In the tradition of China's master builders, the Company designs, executes and maintains the infrastructures that support the progress and expansion of China. Over the past two decades, Gold Horse has become a trusted leader in China in providing exceptional services and technical knowledge. Through Gold Horse's individual and collective expertise, more than 900 international employees provide cost-effective, intelligent solutions in a timely manner. The Company's outstanding dependability, expertise and safety standards distinguish Gold Horse as an emerging leader in China, in the building services marketplace. For more information, visit http://www.GoldHorseInternational.com.
Genesis Partner Announces New Contracts of Nearly $10 Million
Wednesday August 29, 6:30 am ET
BOCA RATON, Fla., Aug. 29, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTC BB:GTEC.OB - News) announced that two new building projects have been started by Gold Horse International. These Western China projects total nearly $10 million and should yield profits of about $1,750,000, according to management.
Mr. Yang Lian Kuan, Chairman and CEO of Gold Horse, also confirmed that Adam Wasserman, Chief Financial Officer, shall arrive in China soon after Labor Day to assist in the completion of the Company's 2007 annual report. This audited financial review, to be filed as 10-KSB with the S.E.C., is being performed by Kabani & Company of Los Angeles, California. ``We are confident that our shareholders will be impressed by the Company's performance over the past 12 months,'' predicted Mr. Yang. Currently, Genesis owns 8.5 million shares in Gold Horse International (OTC BB:SPEH.OB - News), which achieved public company status in late June, having progressed through the Genesis private-to-public, reverse merger program.
ADVERTISEMENT
Gold Horse was the second partner company in the trailing nine months to complete this program. Genesis maintains an active role in Gold Horse's management and business activities, including the assignment of Western directors to assist the company in executing its expanded business model.
Both Genesis and Gold Horse have been encouraged by the performance of another publicly listed company, China Housing and Land Development, Inc., which has a current market cap exceeding $100 million.
About Gold Horse International, Inc.
Gold Horse International, Inc., together with its subsidiaries, is an engineering and construction company that offers general contracting, construction management and design-building services to private clients and public agencies. Regarded as one of China's safest contractors in Western China, the Company's primary objective is to develop, execute, and maintain projects on schedule, within budget, and with excellence. In the tradition of China's master builders, the Company designs, executes and maintains the infrastructures that support the progress and expansion of China. Over the past two decades, Gold Horse has become a trusted leader in China in providing exceptional services and technical knowledge. Through Gold Horse's individual and collective expertise, more than 900 international employees provide cost-effective, intelligent solutions in a timely manner. The Company's outstanding dependability, expertise and safety standards distinguish Gold Horse as an emerging leader in China, in the building services marketplace. For more information, visit http://www.GoldHorseInternational.com.
Antwort auf Beitrag Nr.: 31.536.907 von cenk_2005 am 11.09.07 20:18:26Der letzte macht das Licht aus
Wenn man sich den Chart (OTC) anschaut, sieht man ca. alle 2 Jahre einen Hype... das dürfte ja dann bald mal sein... In diesem Sinne Die Hoffnung stirbt zuletzt...
Wenn man sich den Chart (OTC) anschaut, sieht man ca. alle 2 Jahre einen Hype... das dürfte ja dann bald mal sein... In diesem Sinne Die Hoffnung stirbt zuletzt...
Antwort auf Beitrag Nr.: 31.576.115 von MKostolany am 14.09.07 18:09:04Wer jetzt noch dabei ist kann ja wohl noch warten.
Ich bleibe dabei und hoffe
AlCamus
Ich bleibe dabei und hoffe
AlCamus
Antwort auf Beitrag Nr.: 31.629.974 von AlCamus am 17.09.07 12:47:36 wann kommen den die nächsten quartalszahlen. die letzten waren ja nicht so schlecht, aber leider kommt nichts neues mehr von der firma. schlafen die dort eigentlich?
bald ist olympiade in peking, da sollte doch mal bald was an geschäften laufen.
ich hoffe immer noch das da bald mal was richtig zündet.
wann kommen den die nächsten quartalszahlen. die letzten waren ja nicht so schlecht, aber leider kommt nichts neues mehr von der firma. schlafen die dort eigentlich?bald ist olympiade in peking, da sollte doch mal bald was an geschäften laufen.
ich hoffe immer noch das da bald mal was richtig zündet.
Antwort auf Beitrag Nr.: 31.576.115 von MKostolany am 14.09.07 18:09:04Moin Leute, komm grad vom Feiern...
Hab ich euch nicht den fetten Rebound vorher gesagt?!?!
Denke, dass wir die 0,50$ diese Woche noch erreichen
Auf geht's... alles steuerfrei ... wie geil ist das denn?
Hab ich euch nicht den fetten Rebound vorher gesagt?!?!
Denke, dass wir die 0,50$ diese Woche noch erreichen
Auf geht's... alles steuerfrei ... wie geil ist das denn?
Seh grad knapp 200% und gestern schon > 200%... geil
Antwort auf Beitrag Nr.: 31.826.423 von MKostolany am 03.10.07 02:31:43Nachher mal fettes GAP ,25 € + wid wohl hoch auf ,30€ laufen und wenn jetzt noch der $ gut gestanden wäre... manoman.... geh jetzt glaub ich mal ein bissel schlaf tanken... seh euch ab 9 Uhr... bis nachher
Antwort auf Beitrag Nr.: 31.826.424 von MKostolany am 03.10.07 02:33:53heute auch upa erholung, töchter zogen gestern in usa wieder an...............sagt, heute hier handel ? danke
das war's schon,..
pendelt sich in etwa ein..
schau mer mal ..... weit nach vorn..
pendelt sich in etwa ein..
schau mer mal ..... weit nach vorn..
Guten Morgen
auf zu einer neuen Ralley
auf zu einer neuen Ralley
Antwort auf Beitrag Nr.: 31.826.424 von MKostolany am 03.10.07 02:33:53 war wohl nichts wa, jetzt wird erst mal wieder gedrückt um dann wieder billig einzukaufen.
warten wers ab mir reichts schon wenn sie bis ende des jahres auf 0,40 € wäre
was ich noch schwer bezweifle
war wohl nichts wa, jetzt wird erst mal wieder gedrückt um dann wieder billig einzukaufen.warten wers ab mir reichts schon wenn sie bis ende des jahres auf 0,40 € wäre
was ich noch schwer bezweifle
nicht immer so pessimistisch,werter reiferer
us 0,30 $ = 0,20 e gestern. noch billig also
Genesis Pharmaceuticals Announces Cooperation Agreement with T
e Institute of Microbiology, Chinese Academy of Scien
B: Genesis Pharmaceuticals Announces Cooperation Agreement with The Institute of
Microbiology, Chinese Academy of Sciences ( PrimeNewswire )
LAIYANG, China, Nov 21, 2007 (PrimeNewswire via COMTEX) --
Genesis Pharmaceuticals Enterprises, Inc. (OTCBB:GTEC) ("Genesis" or the
"Company"), a U.S. pharmaceutical company with its principal operations in
the People's Republic of China, today announced that it signed a cooperation
agreement with The Institute of Microbiology, Chinese Academy of Sciences
(IMCAS), a research institution in China that performs a wide spectrum of
basic and applied research in the field of microbiology.
According to the cooperation agreement, Genesis and IMCAS will build a
"Genesis Pharmaceuticals Industrialization Model" to do joint research with
the goal of commercializing pharmaceutical discoveries. This
Industrialization Model is IMCAS' first cooperative arrangement with a
pharmaceuticals manufacturing company.
Genesis will fund the Industrialization Model's daily operations and
research and development activities. Once new drugs have completed a first
stage of experiments in the Industrialization Model, they will be delivered
to Genesis's factory for further testing to determine the viability of
commercial wide-scale production. Genesis' research and development staff
will work with researchers from IMCAS to resolve issues that arise during the
process of designing the manufacturing process for new drugs. Genesis will
have the first right to purchase patents for any products developed by the
Industrialization Model and IMCAS.
"We are very pleased that IMCAS chose Genesis to be its partner in the
commercialization of new drug discoveries," said Mr. Cao Wubo, Chairman and
CEO of Genesis Pharmaceuticals Enterprises, Inc. "Because IMCAS is the
national leading research institution in the field of microbiology, we
believe collaboration will bring valuable research and develop expertise to
Genesis and strengthen our own R&D force. This will extend our company's use
of cutting edge technologies as well as solidify our leading position in the
Chinese pharmaceutical market."
About IMCAS
The Institute of Microbiology, Chinese Academy of Sciences (IMCAS) was
founded on December 3, 1958. It is a national comprehensive research
institution that performs a wide spectrum of basic and applied research in
the field of microbiology. IMCAS hosts 300 faculty and staff, including 5 CAS
academicians. Currently, it has three key laboratories: State Key Laboratory
of Microbial Resources, State Key Laboratory of Plant Genomics, and CAS Key
Laboratory of Systematic Mycology and Lichenology as well as nine research
centers which carry out studies on microbial resources, microbial genomics,
agricultural biotechnology, bio-energy and industrial biotechnology,
environmental biotechnology, extremophiles, microbial metabolic engineering,
molecular virology, and molecular immunology, As the national leading
research and development organization in China, IMCAS successfully developed
SARS vaccine.
As the national leading research institution in the field of microbiology,
the IMCAS is committed to the advancement of science and technology. During
the last 40 years, it has attained a number of developmental achievements in
molecular evolution, pathogenicity, and cross-species propagation, as well as
antiviral fields which can be the initial force for industrialization process.
About Genesis Pharmaceuticals Enterprises
Genesis Pharmaceuticals Enterprises, Inc. is a U.S. public company engaged
in the research, development, production, marketing and sales of
pharmaceutical products in the People's Republic of China. Its operations are
located in Northeast China in an Economic Development Zone in Laiyang City,
Shandong province. Genesis is a major pharmaceutical company in China
producing tablets, capsules, and granules for both western and Chinese
herbal-based medical drugs. The Company maintains a representative office in
the U.S. For more information, refer to http://www.Genesis-China.net
Safe Harbor Statement
Certain statements set forth in this press release constitute
"forward-looking statements." Such statements are not guarantees of future
performance and are subject to risks and uncertainties that could cause the
Company's actual results and financial position to differ materially from
those included within the forward-looking statements. Forward-looking
statements involve risks and uncertainties, including those relating to the
Company's ability to introduce, manufacture and distribute new drugs. Actual
results may differ materially from predicted results, and reported results
should not be considered as an indication of future performance. The
potential risks and uncertainties include, among others, the Company's
ability to obtain raw materials needed in manufacturing, the continuing
employment of key employees, the failure risks inherent in testing any new
drug, the possibility that regulatory approvals may be delayed or become
unavailable, patent or licensing concerns that may include litigation, direct
competition from other manufacturers and product obsolescence. More
information about the potential factors that could affect the Company's
business and financial results is included in the Company's filings,
available via the United States Securities and Exchange Commission.
This news release was distributed by PrimeNewswire, www.primenewswire.com
SOURCE: Genesis Pharmaceuticals Enterprises, Inc.
Genesis Pharmaceuticals Enterprises, Inc.
Ms. Elsa Sung, CFO
877-895-3650, Ext. 701
info@Genesis-China.net
CCG Elite Investor Relations, Inc.
Mr. Crocker Coulson, President
+1-646-213-1915 (New York)
crocker.coulson@ccgir.com
(C) Copyright 2007 PrimeNewswire, Inc. All rights reserved.
*** end of story ***
Genesis Pharmaceuticals Announces Cooperation Agreement with T
e Institute of Microbiology, Chinese Academy of Scien
B: Genesis Pharmaceuticals Announces Cooperation Agreement with The Institute of
Microbiology, Chinese Academy of Sciences ( PrimeNewswire )
LAIYANG, China, Nov 21, 2007 (PrimeNewswire via COMTEX) --
Genesis Pharmaceuticals Enterprises, Inc. (OTCBB:GTEC) ("Genesis" or the
"Company"), a U.S. pharmaceutical company with its principal operations in
the People's Republic of China, today announced that it signed a cooperation
agreement with The Institute of Microbiology, Chinese Academy of Sciences
(IMCAS), a research institution in China that performs a wide spectrum of
basic and applied research in the field of microbiology.
According to the cooperation agreement, Genesis and IMCAS will build a
"Genesis Pharmaceuticals Industrialization Model" to do joint research with
the goal of commercializing pharmaceutical discoveries. This
Industrialization Model is IMCAS' first cooperative arrangement with a
pharmaceuticals manufacturing company.
Genesis will fund the Industrialization Model's daily operations and
research and development activities. Once new drugs have completed a first
stage of experiments in the Industrialization Model, they will be delivered
to Genesis's factory for further testing to determine the viability of
commercial wide-scale production. Genesis' research and development staff
will work with researchers from IMCAS to resolve issues that arise during the
process of designing the manufacturing process for new drugs. Genesis will
have the first right to purchase patents for any products developed by the
Industrialization Model and IMCAS.
"We are very pleased that IMCAS chose Genesis to be its partner in the
commercialization of new drug discoveries," said Mr. Cao Wubo, Chairman and
CEO of Genesis Pharmaceuticals Enterprises, Inc. "Because IMCAS is the
national leading research institution in the field of microbiology, we
believe collaboration will bring valuable research and develop expertise to
Genesis and strengthen our own R&D force. This will extend our company's use
of cutting edge technologies as well as solidify our leading position in the
Chinese pharmaceutical market."
About IMCAS
The Institute of Microbiology, Chinese Academy of Sciences (IMCAS) was
founded on December 3, 1958. It is a national comprehensive research
institution that performs a wide spectrum of basic and applied research in
the field of microbiology. IMCAS hosts 300 faculty and staff, including 5 CAS
academicians. Currently, it has three key laboratories: State Key Laboratory
of Microbial Resources, State Key Laboratory of Plant Genomics, and CAS Key
Laboratory of Systematic Mycology and Lichenology as well as nine research
centers which carry out studies on microbial resources, microbial genomics,
agricultural biotechnology, bio-energy and industrial biotechnology,
environmental biotechnology, extremophiles, microbial metabolic engineering,
molecular virology, and molecular immunology, As the national leading
research and development organization in China, IMCAS successfully developed
SARS vaccine.
As the national leading research institution in the field of microbiology,
the IMCAS is committed to the advancement of science and technology. During
the last 40 years, it has attained a number of developmental achievements in
molecular evolution, pathogenicity, and cross-species propagation, as well as
antiviral fields which can be the initial force for industrialization process.
About Genesis Pharmaceuticals Enterprises
Genesis Pharmaceuticals Enterprises, Inc. is a U.S. public company engaged
in the research, development, production, marketing and sales of
pharmaceutical products in the People's Republic of China. Its operations are
located in Northeast China in an Economic Development Zone in Laiyang City,
Shandong province. Genesis is a major pharmaceutical company in China
producing tablets, capsules, and granules for both western and Chinese
herbal-based medical drugs. The Company maintains a representative office in
the U.S. For more information, refer to http://www.Genesis-China.net
Safe Harbor Statement
Certain statements set forth in this press release constitute
"forward-looking statements." Such statements are not guarantees of future
performance and are subject to risks and uncertainties that could cause the
Company's actual results and financial position to differ materially from
those included within the forward-looking statements. Forward-looking
statements involve risks and uncertainties, including those relating to the
Company's ability to introduce, manufacture and distribute new drugs. Actual
results may differ materially from predicted results, and reported results
should not be considered as an indication of future performance. The
potential risks and uncertainties include, among others, the Company's
ability to obtain raw materials needed in manufacturing, the continuing
employment of key employees, the failure risks inherent in testing any new
drug, the possibility that regulatory approvals may be delayed or become
unavailable, patent or licensing concerns that may include litigation, direct
competition from other manufacturers and product obsolescence. More
information about the potential factors that could affect the Company's
business and financial results is included in the Company's filings,
available via the United States Securities and Exchange Commission.
This news release was distributed by PrimeNewswire, www.primenewswire.com
SOURCE: Genesis Pharmaceuticals Enterprises, Inc.
Genesis Pharmaceuticals Enterprises, Inc.
Ms. Elsa Sung, CFO
877-895-3650, Ext. 701
info@Genesis-China.net
CCG Elite Investor Relations, Inc.
Mr. Crocker Coulson, President
+1-646-213-1915 (New York)
crocker.coulson@ccgir.com
(C) Copyright 2007 PrimeNewswire, Inc. All rights reserved.
*** end of story ***
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 130 | ||
| 129 | ||
| 114 | ||
| 99 | ||
| 56 | ||
| 50 | ||
| 47 | ||
| 38 | ||
| 35 | ||
| 33 |
| Wertpapier | Beiträge | |
|---|---|---|
| 27 | ||
| 24 | ||
| 23 | ||
| 22 | ||
| 22 | ||
| 21 | ||
| 19 | ||
| 17 | ||
| 17 | ||
| 15 |
